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ABSTRACT OF THE DISSERTATION 
TAILORING HEME-THIOLATE PROTEINS INTO EFFICIENT BIOCATALYSTS 
WITH HIGH SPECIFICITY AND SELECTIVITY 
 by 
Hui Tian 
Florida International University, 2010 
Miami, Florida 
Professor Xiaotang Wang, Major Professor 
Cytochrome P450 monooxygenases, one of the most important classes of 
heme-thiolate proteins, have attracted considerable interest in the biochemical community 
because of its catalytic versatility, substrate diversity and great number in the superfamily. 
Although P450s are capable of catalyzing numerous difficult oxidation reactions, the 
relatively low stability, low turnover rates and the need of electron-donating cofactors 
have limited their practical biotechnological and pharmaceutical applications as isolated 
enzymes. The goal of this study is to tailor such heme-thiolate proteins into efficient 
biocatalysts with high specificity and selectivity by protein engineering and to better 
understand the structure-function relationship in cytochromes P450. 
In the effort to engineer P450cam, the prototype member of the P450 superfamily, 
into an efficient peroxygenase that utilizes hydrogen peroxide via the “peroxide-shunt” 
pathway, site-directed mutagenesis has been used to elucidate the critical roles of 
viii 
hydrophobic residues in the active site. Various biophysical, biochemical and 
spectroscopic techniques have been utilized to investigate the wild-type and mutant 
proteins. Three important P450cam variants were obtained showing distinct structural 
and functional features. In P450camV247H mutant, which exhibited almost identical 
spectral properties with the wild-type, it is demonstrated that a single amino acid switch 
turned the monooxygenase into an efficient preoxidase by increasing the peroxidase 
activity nearly one thousand folds. In order to tune the distal pocket of P450cam with 
polar residues, Leu 246 was replaced with a basic residue, lysine, resulting in a mutant 
with spectral features identical to P420, the inactive species of P450. But this 
inactive-species-like mutant showed catalytic activities without the facilitation of any 
cofactors. By substituting Gly 248 with a histidine, a novel Cys-Fe-His ligation set was 
obtained in P450cam which represented the very rare case of His ligation in 
heme-thiolate proteins. In addition to serving as a convenient model for hemoprotein 
structural studies, the G248H mutant also provided evidence about the nature of the axial 
ligand in cytochrome P420 and other engineered hemoproteins with thiolate ligations. 
Furthermore, attempts have been made to replace the proximal ligand in sperm whale 
myoglobin to construct a heme-thiolate protein model by mimicking the protein 
environment of cytochrome P450cam and chloroperoxidase.  
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CHAPTER I. LITERATURE REVIEW 
 
1.1 INTRODUCTION OF METALLOPROTEINS  
    It is an old wisdom that metals are indispensable for life. Nature uses metal ions 
extensively for both structural and functional roles. By incorporating metal ions into 
proteins, a diverse class of biologically significant macromolecules termed 
metalloproteins is created. In fact, about one third to one half of all proteins require 
metals to carry out their functions (1). Metalloproteins can catalyze some of the most 
difficult and yet important transformations in nature, such as photosynthesis, respiration, 
electron transfer, water oxidation, molecular oxygen transport and reduction, and 
nitrogen fixation (2). The significance of iron, copper, and zinc in biological systems 
together with other metals including cobalt, manganese, molybdenum, and nickel has 
been evident for decades (3). The catalytic activities of these metal-containing systems 
depend on both the nature of the metal and the influence of the protein environment 
including the type of ligands provided by the protein, the geometry of the coordination 
sphere and the protein structure in the vicinity of the metal ion.  
A great deal of effort has been devoted to the understanding of the structure and 
function of metalloproteins because of their indispensable roles in biological systems and 
their ability to catalyze some of the most difficult chemical reactions under mild and 
environmentally friendly conditions. Furthermore, such enzymes are able to catalyze 
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regio- and stereo-selective transformations and thus offer products that are critical to the 
producrion of fine chemicals, pharmaceuticals, and many other value-added materials. To 
better understand the critical roles of metalloproteins, protein engineering has been used 
to study their structure-function relationships by either rational design or directed 
evolution.  
1.1.1 Heme-containing proteins 
    Heme is comprised of a tetrapyrrole ring system complexed with an iron atom in the 
center. One or two axial ligands complete the coordination requirement of the heme iron. 
A heme protein (also known as hemoprotein or haemoprotein) contains a heme prosthetic 
group, bound either covalently or non-covalently to the protein. As one of the largest 
classes of metalloproteins, the heme-containing proteins have attracted a great deal of 
attention from the scientific community since the beginning of modern enzymology. 
They have diverse biological functions and are able to catalyze a broad spectrum of 
biological processes ranging from electron transfer (cytochromes) to oxygen storage 
(myoglobin) / transport (hemoglobin) / activation (P450) and molecular sensing (CooA) 
(4-6).  
    Many biochemical and biophysical studies of heme proteins and their variants have 
suggested that the type of reaction catalyzed by different hemoproteins is normally 
controlled by: 1) the nature of the proximal ligand and its surrounding residues, 2) the 
distal environment including conserved significant residues, and 3) the type of heme (7). 
3 
The most common heme prosthetic group is iron protoporphyrin IX also known as heme 
b (Fig. 1.1), which is the prosthetic group found in all the heme proteins discussed in this 
dissertation. The ferriprotoporphyrin IX is made up of four pyrrol rings joined by methine 
bridges with ferric iron in the center of the molecule replacing the two hydrogen atoms 
attached to pyrrol nitrogens. The remaining two axial ligands to the heme iron are located 
above (distal) and below (proximal) the porphyrin plane respectively. Different types of 
heme have different side chains. There are eight side chains in ferriprotoporphyrin IX 
(heme b): four methyl groups at positions 1, 3, 5, and 8, two vinyl groups at positions 2 
and 4, and two propionate groups at positions 6 and 7. The carbon atoms of the methine 
bridges are symbolized as α, β, γ, and δ (8). In many heme proteins, oxygen or hydrogen 
peroxide will bind to the heme iron in the distal site as the proximal site is normally 
occupied by certain amino acid heteroatoms. For example, in most heme peroxidases, 
there is a histidine nitrogen serving as the proximal ligand; while chloroperoxidase, as an 
exception, possesses a cysteinate sulfur ligated to the heme iron. The distal side in these 
cases is the catalytic center, and its coordination state varies in different states of the 
enzyme during catalytic cycles. In some other heme proteins with no directly bound 
oxygen or hydrogen peroxide, both of the axial coordination sites are occupied by 
heteroatoms from the nearby amino acids, like cytochrome c which has a histidine and 
methionine as the axial ligands (9).  
 
4 
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Figure 1.1 Structure of iron protoporphyrin IX, heme b. A-D indicate the location of each pyrrole 
ring and α to δ identify the site of each methane bridge.  
 
    One of the most important questions about heme proteins is how different heme 
proteins achieve such structural and functional diversity by using the same heme 
prosthetic group (5-7). For instance, hemoglobin and myoglobin are O2 carriers and can 
bind O2 reversibly (10, 11); heme oxygenase (HO) and cytochromes P450 activate O2, 
and transfer the oxygen atom to the heme prosthetic group or to other organic molecules 
(12-15); FixL protein, CooA protein and guanylate cyclase serve as biological sensors for 
O2, CO and NO respectively (16). The protein environment, especially near the active site, 
clearly plays an essential role in governing the reactivity of the metal iron, and it could be 
the determining factor that controls the functionalities of the distinct hemoproteins with 
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essentially identical metal centers. Therefore, the redesign of heme proteins, from one 
type into another, not only provides a test of the known factors governing their structure 
and function but also allows the direct comparison of two different heme proteins in the 
same framework to achieve protein variants with better efficiency and selectivity (7).  
1.1.2 Heme-Thiolate Proteins and their structural mimics 
    Heme-thiolate proteins are a group of heme proteins with a thiolate anion from a 
deprotonated cysteine residue serving as the proximal heme ligand (Fig. 1.2 (A)). They 
constitute one of the two major categories of heme-containing proteins found in living 
organisms. The other group is the heme-imidazole proteins whose axial ligand is an 
imidazole group from a hisitidine residue (Fig. 1.2 B). Their difference in the axial ligand 
is also indicated in the optical properties of their reduced forms with carbon monoxide 
bound: the heme-thiolate proteins usually show a characteristic absorption maximum at 
around 450nm, whereas the corresponding absorption spectrum of heme-imidazole 
proteins give a Soret peak at around 420nm (17). Therefore, the optical features of CO 
complexes have generally been used as a probe for the nature of proximal ligation in 
hemoproteins.  
    There are several classes of heme-thiolate proteins reported such as cytochromes 
P450, chloroperoxidase (CPO), nitric oxide synthases (NOS), cystathionine β-synthase, 
the sensor protein CooA and eIF2α kinase (17). Heme-thiolate proteins are essentially 
among the most versatile biocatalysts of the hemoprotein family. They serve as 
6 
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Figure 1.2 Heme centers of heme-thiolate proteins with Cys as the proximal ligand (A), and 
heme-imidazole proteins with His as the proximal ligand (B). 
 
oxidoreductases that perform essential functions in the biological systems. The hallmark 
reaction catalyzed by these enzymes is the substrate oxidation, converting R-H to R-OH 
(18). It has been suggested that the identity of the axial ligands to the heme iron, the 
nature of the heme environment, and the accessibility of the substrate to the active site 
combine to play crucial roles in determining the enzyme activities. Because of the 
similarity of the protein environment that heme-thiolate proteins and heme-imidazole 
proteins share, many studies have been carried out to engineer the heme-imidazole 
proteins by replacing the proximal histidine with a cysteine residue to mimic 
heme-thiolate proteins, in order to better understand the structure-function relationships 
in these heme-containing enzymes.  
    In fact, the proximal thiolate ligation is not kept intact in various oxidation states in 
all heme-thiolate proteins, and in some cases the Fe-thiolate ligation is lost upon 
reduction and carbon monoxide binding. That also happens in many hemoproteins with 
B A 
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engineered iron-thiolate ligands. Table 1.1 listed some examples of the heme-thiolate 
proteins and their mimics with redox-dependent axial ligands in various oxidation states.  
 
Table 1.1. Heme-thiolate proteins and their mimics with redox-dependent axial ligand switches. 
 
Protein Fe (III) Fe (II) Fe (II)-CO Ref 
Heme-thiolate proteins 
P450 Cys/OH- Cys Cys/CO (13) 
CPO Cys/OH- Cys Cys/CO (19-21) 
NOS Cys/OH- Cys Cys/CO (22, 23) 
CooA Cys/Pro His/Pro His/CO (24, 25) 
CBS Cys/His Cys/His His/CO (26, 27) 
Engineered heme-thiolate protein mimics  
Mb H93C Cys His His/CO (28, 29) 
CcP H175C/D235L Cys Cysteic acid Cysteic acid/CO (30) 
Cytochrome c M80C Cys/His His His/CO (9) 
Heme oxygenase H25C Cys/H2O  CO (31) 
NP1 H60C Cys H2O CO (32) 
Cytochrome b5 H39C Cys/His His His/CO (33) 
 
For instance, in the CO-sensing transcriptional activator CooA, the Cys75 axial 
ligand of the ferric heme is exchanged to His77 upon reduction and CO activation. 
Therefore, the electronic absorption spectrum of CO-complex of CooA exhibits the Soret 
band at around 420nm instead of 450nm, typical of thiolate-ligated hemoproteins (25). In 
the listed hemoproteins with engineered heme-thiolate ligations in their ferric forms 
(Table 1.1), upon reduction the iron-thiolate ligands are all lost either by oxidation, 
dissociation or protonation, resulting in ferrous-CO complexes with 420-nm Soret 
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absorption maxima. Heme oxygenase uses His-25 as its proximal iron ligand. The 
substitution of His-25 with a cysteine results in a 6-coordinated ligation of the iron to a 
cysteinate and water molecule, but the Fe-Cys bond is lost upon being reduced and the 
ferrous heme is only loosely bound to a postulated water molecule (31).  
 
1. 2 CYTOCHROMES P450  
Cytochrome P450 (CYP) monooxygenase, a red pigment first found in liver 
microsomes and named for its spectral properties, is one of the most important 
heme-thiolate proteins. The ability of P450s to functionalize unactivated hydrocarbon at 
physiological conditions has attracted considerable interests from the chemical and 
biological communities (13). There are several books dedicated to the superfamily of 
P450 enzymes (14, 34-39). Many reviews have elaborated the chemistry, structure and 
functions of P450s (13, 40-44). The P450 enzymes have been identified in all domains of 
life and more than 11,500 distinct CYP proteins had been known and named as of Feb. 
2009 (45). In all P450s, the heme-thiolate ligation is highly conserved in the proximal 
side of the active site and is considered to play critical roles in the catalytic mechanisms. 
The cytochromes P450 perform regio- and stereo-specific reactions under physiologial 
conditions and the most common reaction catalyzed by cytochrome P450 is a  
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monooxygenase reaction in which one atom of oxygen is inserted into an organic 
substrate (RH) while the other oxygen atom is reduced to water (Eq. 1).  
     R-H + NAD(P)H + H+ + O2           R-OH + NAD(P)+ + H2O            (1) 
The P450s generally require two electrons from either NADH or NAD(P)H to 
activate O2, and the electrons are transferred to the heme of P450 via a protein electron 
transport system, usually a reductase and an iron-sulfur protein, depending on the type of 
P450s. In addition to hydroxylation, P450s are able to catalyze a number of other 
significant reactions as listed in Table 1.2. The catalytic versatility, substrate diversity and 
sheer number of P450s have lead to considerable interest over the last few decades in the 
engineering of P450 enzymes for a variety of purposes.  
 
Table 1.2 Cytochrome P450-catalyzed reactions (34, 46). 
C-H hydroxylation CH COH  
Epoxidation 
O
 
Allylic Rearrangement 
R R

 
Desaturation  
Reductive Dehalogenation 
 
 X





 
P450
10 
Oxidative Dehalogenation 
X OH  
Alcohols oxidation 


C C C
O
 
Aldehyde oxidation C C
O
C
OH
O
 
Deformylation 
OH
 
Oxidative deformylation 
R1
R2
R3
CHO
R4
R1
R2
R3
R4
HCOOH
 
Sulfoxidation R S R' R S R'
O
 
N-Dealkylation N R N H
 
O-Dealkylation  R O CH2R' ROH R'COH  
N-Oxygenation 
R NH2 R NH2
OH
 
Peroxidase-type oxidation 
R
R
O
R
OH
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1.2.1 Catalytic cycle of P450s 
    The generally accepted catalytic cycle of P450 enzymes is shown in Fig. 1.3 (34). 
The resting state (1) is a six-coordinate, low-spin ferric heme, with poryphyrin nitrogen 
atoms occupying the four equatorial position and cysteine and water serving as the axial  
ligands at the proximal and distal sides, respectively. The catalytic cycle is initiated by 
the substrate binding in the protein active site followed by the displacement of the distal 
water molecule, converting the six-coordinate low-spin ferric heme to a predominantly 
five-coordinate high-spin form (intermediate (2)) (47). In the meantime, the reduction 
potential is increased by greater than +100mV (substrate-dependent) upon substrate 
binding, which has been shown to initiate electron transfer to the heme from NAD(P)H 
via native reductase proteins (48). The first electron transfer leads to the reduction of 
ferric to ferrous heme (intermediate (3)), followed by dioxygen binding at the ferrous 
heme iron, yielding an unstable ferrous-oxy species (intermediate (4)). The second 
electron transfer is suggested to be the rate- limiting step in the cycle followed by 
protonation and the formation of the hydroperoxo-iron complex (intermediate (6), 
Compound 0). Then this species is further protonated to generate highly reactive 
Compound I (49), ferryl-oxo porphyrin π-radical cation, the key intermediate (7) in the 
catalysis (Fig. 1.4). This step involves the heterolytic splitting of the oxygen-oxygen 
bond and the releasing of a water molecule. A highly conserved threonine residue near 
the heme has been suggested to play an essential role to relay protons from the solvent to 
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the heme (50, 51). Finally, the Fe-ligated oxygen atom is transferred to the substrate 
through intermediate (8) followed by hydroxylation and regeneration of the resting state. 
 
 
 
Figure 1.3 The cytochrome P450 catalytic cycle including the “peroxide-shunt pathway”. RH is 
substrate and ROH is the product. The porphyrin molecule is represented as a parallelogram. 
Intermediates (6) and (7) are Compound 0 and Compound I respectively.  
Cpd 0 
Cpd I 
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Figure 1.4 P450cam putative oxygen complex, Compound I. The heme prosthetic group is 
colored in yellow, the substrate is in gray and the bound dioxygen is in red. All other amino acids 
are depicted in lines and ribbons. This image was created from the crystal data (PDB code 1DZ9) 
using PYMOL (52).  
 
    In the standard catalytic cycle, Compound I would hydroxylate the substrate and 
regenerate the P450 resting state. Although the main steps mentioned above are similar 
for all P450 enzymes, each step is far from being simple and many side reactions exist 
leading to the leakage of the cycle (34).  
 
 
 
 
 
14 
1.2.2 “Peroxide-shunt” pathway  
    In the absence of reducing cofactors, partner proteins and dioxygen, P450s are 
capable of utilizing hydrogen peroxide or organic peroxy compound as the oxidant to 
hydroxylate substrates through the “peroxide-shunt” pathway (Eq. 2) (14): 
RH + R’OOH               ROH + R’OH            (2) 
    As illustrated in Fig. 1.3, the shunt pathway bypasses a large portion of the standard 
catalytic cycle by eliminating the rate-limiting electron transfer steps and directly results 
in the generation of the FeIII-OOH- complex (Cpd. 0). There are many studies about the 
P450 peroxide shunt pathway (53-59). This type of reaction is not suggested to be 
physiological, since the turnover rate is quite low and high concentrations of peroxide are 
needed to achieve the optimal reaction rate. But on the other hand, some unique P450 
enzymes have been reported to function as peroxygenases by utilizing hydrogen peroxide 
or the peroxide groups of their subsbtrates as the oxygen donor with high catalytic 
turnover rates, compared with a normal monooxygenation reaction or the peroxide-shunt 
reaction catalyzed by common P450s (60-66). The “peroxygenase” activity of P450s has 
definitely broadened the versatility of the superfamily and offers a possibility to utilize 
cell-free P450-dependent catalysis without the requirement of NAD(P)H, and auxiliary 
proteins.  
 
 
P450
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1.2.3 P450 Structure 
    In the massive superfamily of cytochrome P450s, there are more than 11,500 distinct 
CYP proteins known to date, while the sequence identities between the P450 families are 
generally low (about 10-30%) (45, 67). Despite the sequence diversities, P450 in many 
different families and many different organisms share a high degree of structural 
conservation in their secondary and tertiary folds (34, 68, 69). So far, there are over 300 
unique P450 structures available in the Protein Data Bank. Most P450 enzymes are 
normally described as consisting of α helical and β sheet domains. Unlike peroxidases 
which clearly fold into N- and C-terminal helical-rich domains with the heme sandwiched 
between the helices from each domain, P450s do not fold into distinctly divided N- and 
C-terminal domains. For example, cytochrome P450cam, the first protein to be 
crystallized in the P450 superfamily, divides into a helix-rich domain on the right side 
and a β-sheet-rich domain on the left side (Fig. 1.5). The heme group is bracketed 
between the proximal helix L and distal helix I in the C terminal half of the molecule, 
while a majority of the β-structure is also in the C-terminal half but located far from heme 
(70, 71).  
   The heme prosthetic group is deeply embedded in the hydrophobic interior, which 
itself provides the largest hydrophobic surface for interactions with the substrates. The 
heme is oriented nearly parallel to the surfaces between helices L and I with no 
significant exposure to the protein surface (13). The most distinct structural feature of 
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P450 is the presence of an unusual proximal ligation, thiolate sulfur provided by a 
deprotonated cysteine residue. It has been generally agreed that the Cys thiolate ligand to 
the heme iron and its surrounding protein environment play unique and critical roles in 
P450 catalysis. In P450s, the protein architecture surrounding the proximal Fe-Cys 
ligation is highly conserved. In almost all P450s with known structures, the peptide NH 
of the Cys ligand is the proton donor in an H-bond with a peptide carbonyl O atom, 
which forms a tight structure placing the Cys sulfur atom in a position surrounded by  
 
Figure 1.5 Crystal Structure of cytochrome P450cam showing the key elements of secondary 
structure in different colors. This figure was generated from the crystal data (PDB code 2CPP) 
using PYMOL (70). 
E
L 
A 
N-term 
β2 
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I 
G 
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D 
F 
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peptide NH groups forming H-bonds with the thiolate ligand (34). For instance in 
cytochrome P450cam, the sulfur from Cys357 is surrounded by three amide protons from 
Leu358, Gly359 and Gln360, which have been reported to stabilize the coordination of 
the anionic thiolate ligand to the reduced heme iron and also control the “push” effect of 
the thiolate ligand (70, 72). Other P450 enzymes including P450BM3, P450eryF, and 
P450terp also possess such NH-S hydrogen bonds (67, 73, 74). This characteristic feature 
has also been found in other heme thiolate enzymes, such as CPO utilizing two of the 
three NH-S hydrogen bonds and NOS accepting an additional H-bond from the indole 
NH of Trp (20, 75). 
 
 
1.3. HEME PEROXIDASES 
    Nonmammalian heme peroxidases and cytochrome P450s are often grouped 
together because they both contain a single low-potential ferriprotoporphyrin IX (Fig. 1.1) 
and share similar intermediates in their respective catalytic cycles (76). The first heme 
peroxidase crystal structure solved was yeast cytochrome c peroxidase (CcP) (77) 
followed by the first P450 structure (70). Heme peroxidases have played a key role in the 
development of modern enzymology. They are ubiquitous enzymes that catalyze one 
electron oxidation of various micro- and macromolecular substrates by utilizing hydrogen 
peroxide or lipid hydroperoxides as the oxidant, except for chloroperoxidase which is a 
heme-thiolate protein and performs two-electron oxidations as well (8, 78-80). Almost all 
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functionally related peroxidases, such as horseradish peroxidase or cytochrome c 
peroxidase, possess a histidine proximal ligand. The crystal structure studies of the heme 
peroxidases have firmly established the similarity in their active site architecture: 
histidine and arginine in the distal side serving as a proton acceptor from hydrogen 
peroxide and a charge stabilizer, respectively, and heme-bound histidine and 
hydrogen-bonded aspartic acid in the proximal side of the heme prosthetic group (81-85).  
1.3.1 Catalytic cycles 
    Most heme peroxidases follow the reaction scheme as shown in equations (3-5) and 
share common reaction intermediates, Compound I and Compound II (8, 86, 87) 
Resting state (Fe3+) + H2O2 → Compound I (Fe4+=O, R·) + H2O            (3) 
Compound I (Fe4+=O, R·) + SH → Compound II (Fe4+=O) + S·            (4) 
Compound II (Fe4+=O) + SH → Resting state (Fe3+) + S·+ H2O             (5) 
    The catalytic cycle begins with the coordination of one equivalent of hydrogen 
peroxide to the resting ferric peroxidase. The bound peroxide undergoes rapid heterolytic 
cleavage to produce the active intermediate Cpd I, the ferryl-oxo porphyrin cation radical, 
where R is the organic moiety of the heme or an amino acid residue, similar to 
cytochrome P450s (88). This is a two-electron oxidation/reduction reaction, in which the 
enzyme is oxidized and hydrogen peroxide is reduced to water. In the following steps, 
Cpd I is reduced by an organic substrate, usually an aromatic molecule to give a substrate 
radical, to the resting state in two sequential one-electron transfer reactions via a second 
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active intermediate, Cpd II, a ferryl-oxo porphyrin complex (87, 89). It is different from 
P450s which oxidize substrates by inserting one O2-derived oxygen atom into a substrate 
C-H bond.  
    The ability to react rapidly with hydrogen peroxide to form Cpd I has distinguished 
peroxidases from other hemoproteins. This characteristic reactivity has a great deal to do 
with the influence of the protein environment around the heme center. In most heme 
peroxidases, there is a highly conserved hisitidine residue in the distal pocket of the 
active site (82-85, 87, 90-93). Many studies have shown that the distal His plays a critical 
role as a general acid-base catalyst in the formation of Cpd I in the peroxidase catalytic 
cycles (87, 94-97). It is proposed that the conserved His facilitates the generation of the 
initial Fe-OOH complex by deprotonating an approaching hydrogen peroxide as a base 
and subsequently heterolytically cleaving the O-O bond by protonating the departing 
distal oxygen as an acid (Fig .1.6) (98). Also, a network of hydrogen bonds is reported to 
assist the distal histidine in its catalytic role in many heme peroxidases such as 
horseradish peroxidase (Asn-70 H-bonded to His-42), cytochrome c peroxidase, lignin 
peroxidase and Arthromyces rhamosus peroxidase, and others (81, 84, 91, 99).  
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Figure 1.6 Mechanism of Compound I formation in heme peoxidases with distal His. 
 
1.3.2 “Push-Pull” mechanism compared with P450s 
It is intriguing that heme peroxidases and cytochrome P450 enzymes perform 
distinct physiological functions while using the same cofactor. Nevertheless, they do 
share the same key, highly reactive intermediate in their catalytic cycles, Cpd I. It has 
been reported that the proximal ligand and some distal residues in these heme proteins 
play significant roles in the promotion of the hereolytic rupture of the O-O bond of 
dioxygen or peroxides and the following formation of Cpd I, but through different 
mechanisms because of different structural features. For many heme peroxidases, a 
general “push-pull” mechanism has been proposed for this process (Fig. 1.7 (A)) (80, 88, 
100). The “push” effect is provided by the proximal histidine ligand whose electron 
donor capabilities are enhanced through the H-bonding to a nearby carboxylate group 
(e.g., Asp). Meanwhile, the distal histidine accepts a proton from the oxygen atom of 
hydrogen peroxide that binds to the heme iron and transfers it to the other oxygen to form 
a leaving group. A nearby cationic residue (e.g., protonated Arg) in the distal pocket 
21 
works in concert with the hisitidine to facilitate the O-O bond cleavage. The combination 
of the distal histidine and arginine has been suggested to provide the “pull” effect (13).       
 
        
 
 
 
Figure 1.7 “Push-pull” mechanisms for O-O bond cleavage of both heme-imidazole protein (A) 
and heme-thiolate protein (B), such as horseradish peroxidase and P450 respectively. (13) 
 
    However, cytochrome P450 lacks such distal machinery. It possesses a cysteine 
proximal ligand, rather than a histidine typical of most peroxidases. This proximal 
thiolate ligand has been implicated as a crucial factor to facilitate the heterolytic scission 
of the O-O bond through its “push” effect by serving as a strong internal electron donor 
(Fig. 1.7 (B)) (13, 80, 101-104). The cysteine thiolate enables the protonation of Cpd 0 by 
the facilitation of Asp and Thr that exist in the protein pocket (14). Once the O-O bond is 
B A 
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heterolytically cleaved, the electron-releasing axial thiolate ligand would help to stabilize 
the high-valent nature of Cpd I (13).  
1.3.3. Chloroperoxidase: a P450-peroxidase hybrid  
    Chloroperoxidase is an enzyme discovered by Hager and coworkers about 50 years 
ago from the marine fungus Calduriomyces fumugo (105). CPO serves as one of the most 
diverse and versatile known heme peroxidases. CPO and cytochromes P450 share a 
number of physiochemical properties, but they do have clear functional and structural 
differences (106). In addition to its biological role in halogenation of organic molecules, 
CPO is also able to use hydrogen peroxide as the oxidant to catalyze one- and 
two-electron classical peroxidase reactions and P450- and catalase-type reactions under 
acidic conditions. These enzymatic properties have made CPO a very promising 
industrial biocatalyst. Cytochrome P450, on the other hand, is a monooxygenase that 
activates dioxygen to catalyze the hydroxylation of hydrocarbons. Therefore, it is 
important to define the structural details that differentiate the chemical activities 
demonstrated by CPO and P450. 
    CPO, with 299 amino acids, is a single polypeptide consisting of eight helical 
segments and one small β pair. Structurally CPO has a P450-like proximal heme 
environment with cysteinate sulfur as the axial ligand and a peroxidase–like distal heme 
pocket in that polar residues form the peroxide-binding site, and was thus considered as a 
P450-peroxidase hybrid (20). Despite the functional properties shared with other 
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peroxidases and P450s, the tertiary structure of CPO bears little resemblance to either 
peroxidases or P450s. In the CPO distal pocket, though polar as in other peroxidases, a 
glutamic acid instead of a histidine is responsible for the cleavage of the O-O bond in the 
formation of Cpd I (Fig. 1.8).  
  
Figure 1.8 Proposed mechanism of compound I formation catalyzed by Chloroperoxidase. 
 
    In this mechanism, the activation of hydrogen peroxide is initiated by its binding to 
the heme in the distal side. The deprotonated Glu183 abstracts a proton from the substrate 
hydrogen peroxide, and then the formed hydroperoxo-anion binds to the heme iron, 
yielding a ferric-hydroperoxo species known as Compound 0. Glu183 then protonates the 
distal oxygen of Cpd 0 and the peroxide O-O is cleaved heterolytically to generate Cpd I 
and release a water molecule, similar to other peroxidase mechanisms (107, 108). CPO is 
adept in catalyzing a number of chiral oxidations with high yields and high 
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enantioselectivity, in addition to alkyne hydroxylation and heteroatom dealkylation 
(109-114). The stereoselective ability of CPO in catalysis is suggested to be based on its 
unique active site structure and unique catalytic mechanism, which make it the promising 
candidate for industrial catalysts.  
 
1.4 PROTEIN ENGINEERING OF P450S AND HEME PEROXIDASES 
Heme-containing proteins are primary targets of enzyme engineering because of their 
distinct activities and versatile functions. The diversity of function and spectroscopic 
characteristics of this class of proteins have been attributed to the structural components 
and interactions around the heme prosthetic group, especially the identity of the proximal 
axial ligation and the residues located in the distal pocket. The hemoproteins have been 
extensively studied by protein engineering to help test structure-based mechanistic 
hypotheses and evaluate the roles of important residues in enzyme catalysis, which often 
involves the change of substrate specificity, reaction selectivity and efficiency of the 
enzymes.  
As mentioned before, cytochromes, globins, and most peroxidases utilize histidine as 
the proximal ligand, while cytochromes P450, chloroperoxidase and nictric oxide 
synthase use a cyseine thiolate ligand. Together with biochemical, biophysical and X-ray 
crystallographic techniques, site-directed mutagenesis studies have greatly contributed to 
the understanding of the structure-function relationships of hemoproteins and the key 
25 
structural features governing the variability by achieving structural mimics of different 
proteins. Substitution of the amino acids in the active site could make it possible to alter 
the protein axial ligand and to explore the interconversion of functions among 
hemoproteins, based on structure comparisons. In the following section, the mutagenesis 
results that demonstrate the importance of protein structure in controlling heme activity 
and the ability to engineer functions in some important examples of peroxidases and 
P450 are described.   
1.4.1 Cytochrome c peroxidase H52L & H175C 
    Like many other heme peroxidases, cytochrome c peroxidase (CcP) belongs to the 
heme-imidazole protein family with a histidine serving as the axial ligand (H175) to the 
heme iron. In the distal side of the heme group, there is a conserved histidine residue 
(His52) (81). To investigate the role that histidine plays in the reaction of CcP with 
peroxide, His52 was replaced with a nonpolar leucine residue. Although no dramatic 
changes in the structure or in the accessibility of heme binding sites were observed, the 
H52L mutant displayed a 105-fold decrease in catalytic rate compared with that of the 
wild type (115). In addition, the reactivity of the H52L mutant with peroxide was pH 
dependent and affected by the buffer. The pH-dependent study of this mutant has 
indicated that the distal histidine plays crucial roles in the rapid reaction of CcP with 
peroxide and it is more complex than simply being a base catalyst during the initial 
formation of Cpd I (116). 
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    On the other hand, the proximal histidine ligand has been substituted by a cysteine. 
The successful introduction of a thiolate ligand into a peroxidase system naturally with 
histidine axial liagtion would shed light on the roles of His and Cys in the catalytic 
activities of peroxidases by comparing the structure and function of the two heme 
ligations in similar surroundings. In addition, by monitoring the changes in the structural, 
functional and spectroscopic properties of the switched thiolate ligation could offer 
insight into the question about how the thiolate-heme center performs such distinct and 
diverse functions in various hemoproteins. The initial attempt to prepare a thiolate-ligated 
CcP H175C mutant led to Cys oxidation to cysteic acid (117). In the crystal structure 
studies of P450 and CcP, it has been shown that P450 has a hydrophobic environment 
surrounding the proximal thiolate ligand provided by a conserved Phe residue, while in 
CcP there is a negatively charged Asp which forms hydrogen bonds to the proximal 
His175 ligand. The Asp235 residue was proposed to be critical in forming a stable 
heme-thiolate ligation in the resting state of the CcP H175C variant (30).  
1.4.2 P450cam C357H 
    In cytochrome P450cam, the crystal structure has demonstrated that the specific 
cysteine bound to the heme iron is Cys357 (70). To investigate the functional and 
structural roles of the proximal thiolate ligand in P450cam, the axial Cys357 has been 
replaced by a histidine (118, 119). The importance of the thiolate coordination for the 
P450 activities has been exemplified by their inactive forms P420, in which the thiolate 
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ligation is lost (120, 121). The P450cam C357H mutant exhibits greatly decreased 
camphor oxidation activity, and the heterolytic/ homolytic ratio of the O-O bond cleavage 
in the reaction with cumene hydroperoxide, also the electron transfer rate is much slower 
than that of the wild type. However, the mutant shows greater peroxidase activity because 
of the axial ligand alteration. To clarify the roles of the thiolate coordination in the 
heme-thiolate proteins, the axial histidine of myoglobin has been replaced with a cysteine 
(Mb H93C) and the altered thiolate ligand accelerates the heterolytic scission of peroxide 
O-O bond and enhances the styrene epoxidation activity aided by hydrogen peroxide. 
These results have confirmed the important roles of the thiolate ligand plays in 
hemoproteins play in facilitating the O-O bond cleavage to form the active intermediate 
Cpd I and in protein folding, substrate binding and electron transfer.  
1.4.3 CPO C29H & CPO E183H 
    Chloroperoxidase (CPO) is unique in structure since it shares features with both 
peroxidases and P450 enzymes. As in cytochromes P450, CPO has a cysteine heme 
ligand (Cys29) in the proximal side of the heme prosthetic group. However, in contrast to 
the results of P450cam C357H, the thiolate coordination in chloroperoxidase is suggested 
to be not as important as in P450. After substituting the proximal thiolate ligand (Cys 29) 
with a histidine, the CPO C29H was found to retain most (around 80%) of its chlorination, 
peroxidation, epoxidation and catalase activities compared to those of the wild type 
protein (114). These are surprising observations in consideration of many suggestions for 
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the significance of the proximal thiolate ligand in P450. These unexpected results could 
be interpreted by the different mechanisms of the heterolytic O-O bond cleavage in CPO 
and P450 catalytic cycles.  
    As the results of CPO C29H mutant downplayed the importance of thiolate ligation 
in CPO activity, it has been suggested that the distal environment of the heme active site 
plays the major role in controlling the versatile functions of this enzyme. Although, like 
peroxidases that have polar distal pocket, CPO does not possess a histidine residue which 
is normally conserved in the distal helix as the general acid-base catalyst in the formation 
of Compound I. Instead, a glutamic acid at position 183 distal to the heme group takes 
over this function, based on the crystal structure of CPO (20). To investigate the role 
E183 plays in CPO catalysis, it has been replaced by a histidine residue. The results have 
shown that this substitution is destructive to CPO activity, especially its chlorination and 
dismutation activity, which are reduced by 85% and 50%, respectively (122). This 
indicated that Glu-183 is important but not essential to the chlorination and the catalase 
activity of CPO. However the epoxidation activity of the CPO E183H mutant was 
surprisingly increased by about 2.5 times than that of the wild type. The crystal structure 
of CPO identified a proton shuttle among Glu183, His105, and Asp106. Replacement of 
glutamic acid with a hisitidine could partially destroy the triad, resulting in the inhibition 
of chlorination activity but acceleration epoxidation activity.  
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    In summary, mutagenesis studies have shown that the axial ligands in P450s and 
peroxidases do play essential roles in their catalysis. Key factors that determine the 
functional specificity of hemoproteins include the nature of the proximal ligands as well 
as the architecture of the distal site. The remainder of the dissertation details my effort to 
tailor heme-thiolate proteins, specifically cytochrome P450cam, into efficient biocatalysts 
with high specificity and selectivity by redesigning the protein through change of 
residues in the distal pocket, in an effort to elucidate the key structural and functional 
roles of critical amino acids in this protein.  
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Chapter II. SINGLE AMINO ACID SWITCH TURNS P450CAM FROM A 
MONOOXYGENASE INTO AN EFFICIENT PEROXIDASE 
 
2.1 SUMMARY 
Most heme peroxidases contain a highly conserved histidine that serves as the 
general acid-base catalyst at the distal side of the heme prosthetic group in the formation 
of compound I. In contract, cytochromes P450 do not have such obvious acid-base 
groups in their hydrophobic distal heme pockets. To explore the possibility of engineering 
cytochrome P450cam into an efficient peroxygenase via the “peroxide-shunt” pathway, 
Val247 located closely to the heme iron in the distal helix has been substituted with a 
histidine residue. The V247H mutant shows essentially identical optical spectral features 
compared to those of wild type P450cam in the absence of substrate camphor, suggesting 
that the heme-Cys ligation in the parent protein is kept intact in the mutant. Surprisingly 
this mutant does not bind camphor like the wild type, possibly due to unfavorable 
conformational changes in the distal helix which prevents camphor from entering the 
substrate binding site in the same way. However, the V247H mutant has acted as a 
self-sufficient enzyme with significantly higher peroxidase activity compared with wild 
type protein, showing even higher activity than chloroperoxidase. Various spectroscopic 
studies including UV, RR, CD and NMR coupled with electrochemical studies have  
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provided insights into the structural changes that correlate with the observed catalytic 
activities of this mutant.  
 
2.2 INTRODUCTION 
    Cytochromes P450 constitute a superfamily of heme-containing monooxygenases 
that are found ubiquitously in many bacteria, all archaea, fungi and many higher 
eukaryotes. The P450 enzymes are involved in the activation of dioxygen for the 
insertion or addition of one atom of oxygen to a wide variety of substrates, making them 
crucial to many biotransformations such as steroid hormone biosynthesis, drug 
metabolism, detoxification of xenobiotics, and molecular signaling (1-3). The reactions 
catalyzed by P450s include epoxidation, dealkylation, hydroxylation, dehalogenation, and 
heteroatom oxidation (4). The most distinctive structural feature of cytochromes P450 is 
the coordination of a deprotonated cysteine to the heme iron as the proximal ligand, while 
many other hemoproteins possess a histidine at the proximal side. Thus P450s belong to 
the family of so-called heme-thiolate proteins, together with choloroperoxidase (CPO) 
from Caldariomyces fumago, nitric oxide synthase (NOS), cystathionine β-synthase, and 
etc. The proximal thiolate ligand in P450s has been proposed to play a vital mechanistic 
role in providing the “push” effect which enables the heterolytic O-O bond cleavage to 
generate activated iron (IV)-oxo porphyrin radical cation species commonly called CpdI, 
leading to subsequent substrate oxidation (5-7).  
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    The typical P450 catalytic cycle involves substrate binding, dioxygen binding, 
two-electron transfers, followed by CpdI formation and substrate oxidation. With a few 
exceptions, the catalysis of the diverse reactions by P450s all require an external source 
of reducing equivalents and auxiliary proteins (e.g., putidaredoxin, and puridaredoxin 
reductase for P450cam). The requirement of expensive cofactors and the complication 
caused by additional proteins is the limitation to the application of P450s as oxygenases. 
Some P450s are capable of accepting hydrogen peroxide or an organic peroxy compound 
as an oxidant to catalyze oxygen insertion through the so-called “peroxide-shunt” 
pathway in the absence of electron transport proteins and the NAD(P)H cofactor (8-13). 
However, P450s are typically not efficient in their utilization of hydrogen peroxide, the 
natural substrate for peroxidases, as the source of oxygen atom in the monooxygenation 
reactions.  
  Serving as the prototype member in the superfamily, cytochrome P450cam from 
Pseudomonus putida has been extensively studied using various physical and chemical 
techniques. It catalyzes the regio- and stereo-specific hydroxylation of its natural 
substrate d-camphor to 5-exo-hydroxy-camphor (15). A great deal of effort has been 
made to suitably engineer this enzyme by directed evolution and active site modification 
for the oxygenation of significant unnatural substrates. It is still quite important to 
understand the roles of the active-site components in the reactivity, stability, specificity 
and substrate recognition of this enzyme after its discovery decades ago.  
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    To explore the possibility of converting P450cam into an efficient self-sufficient 
peroxidase, we attempted to modify the heme distal side elements that play crucial 
mechanistic roles in this protein’s catalytic functions. In most heme peroxidases, a distal 
histidine is highly conserved in the active site and serves as a general acid-base catalyst 
that is necessary for the formation of CpdI by donating a proton to the Fe3+-OOH moiety 
to promote the heterolytic cleavage of the O-O bond in the peroxidase reaction cycles 
(16-19). It has also been proposed that a functional nitrogen (such as the nitrogen of 
His42 in HRP or His52 in CcP), located at a suitable distance from the heme iron, can 
behave as an acid-base catalyst in hemoproteins (16, 20). Additionally, some unique P450 
enzymes have been shown to function as peroxygenases by utilizing hydrogen peroxide 
as the oxygen donor with extremely high catalytic turnover rates compared to their 
normal monooxygenation reactions as well as the peroxide shunt reaction catalyzed by 
the common P450s (12, 21). A common structural feature about these proteins is that the 
distal side of the heme molecule is quite hydrophilic, which allows H2O2 to enter the 
active site followed by the formation of CpdI with the interaction of the carboxyl group 
of substrate and the Arg residue located near the heme (12). 
    In contrast, P450cam possesses a very hydrophobic distal environment that lacks the 
distal machinery of the peroxidases mentioned above. Therefore, to probe the roles of the 
nonpolar amino acids in the distal helix and to make an efficient peroxygenase, we 
substituted a distal residue with a hydrophilic histidine which is highly conserved in other 
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heme peroxidases. In the distal pocket of P450cam, camphor is bound in a specific 
orientation above the heme iron, with a hydrogen bond between the camphor carbonyl 
and the phenol side chain of Tyr96 as well as numerous non-covalent contacts with active 
site residues (22). Val247 is one of the neighboring residues in the distal pocket that have 
hydrophobic contact with the substrate camphor (23). In light of its proximity to the heme 
prosthetic group, it served as a logical choice for our target (Fig. 2.1). The substitution of 
Val247 with a histidine was anticipated to provide a functional nitrogen from the 
imidazole group of His247 that could act as an acid-base catalyst via the peroxide-shunt 
pathway to facilitate the generation of Cpd I that affords substrate oxidation.  
    Various spectroscopic techniques were utilized in the present work for the structural 
and functional characterizations of the P450cam V247H mutant. In addition to electronic 
absorption spectroscopy, resonance Raman spectroscopy is well established as a highly 
sensitive probe of the active-site structure of heme proteins by providing detailed 
structural information on iron spin and ligation states. Circular dichroism was performed 
to examine the secondary and tertiary structural changes of the mutant. Proton nuclear 
magnetic resonance spectroscopy, one of the most powerful methods for high resolution 
structural characterization of paramagnetic metalloproteins, was also utilized to 
characterize the active site structure of the cyanide complexes of the wild type and 
mutant proteins.  
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Figure 2.1 The active site structure of camphor-bound cytochrome P450cam: the heme 
(salmon), camphor (gray) and some selected residues including distal V247 (green) in 
P450cam are shown. The figures were generated from the crystal data (PDB code 2CPP) using 
PYMOL (22). 
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Additionally, redox potential measurements of the protein were performed to show the 
effect of the amino acid substitution on the redox property of the heme iron. 
 
2.3 EXPERIMENTAL PROCEDURES 
2.3.1 Materials 
    The PfuUltra High-Fidelity DNA polymerase used for site-directed mutagenesis was 
from Stratagene and the primers for the mutation were synthesized by Eurofins MWG 
Operon (Huntsville, AL). Dithiothreitol (DTT), carbon monoxide, hydrogen peroxide, 2, 
2’-Azino-bis (3-Ethylbenzthiazoline-6-Sulfonic Acid), and - aminolevulinic acid were 
purchased from Sigma-Aldrich (St. Louis, MO). Yeast extract, tryptone, glycerol, sodium 
chloride, sodium bromide, sodium acetate, sodium dithionite, potassium chloride, 
potassium phosphate, potassium cyanide, potassium hydroxide, EDTA, Tris-HCl, 
isopropyl-β-D-thiogalactopyranoside (IPTG), Ribonuclease A, Deoxyribonuclease I, 
phenylmethylsulfonyl fluoride (PMSF), lysozyme, hemin, DL-tyrosine and DL-camphor 
were obtained from Fisher Scientific (Pittsburgh, PA). DEAE sepharose fast flow and 
Sephadex G-75 were purchased from GE Healthcare (Piscataway, NJ). All chemicals 
were used without further purification. Choloperoxidase (CPO) from Caldariomyces 
fumago was prepared in our own lab with Rz value over 1.40.  
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2.3.2 Bacterial strains, plasmids and DNA manipulations 
    The bacterial strains used were E. coli NovaBlue and E. coli Rosetta II (DE3) from 
Novagen (Gibbstown, NJ). The plasmid pUS200, constructed by Unger et al., contains a 
1578-bp fragment of P. putida (ATCC 17453) P450cam plasmid fragment inserted into 
the PstI and HindIII sites of pEMBL8+ (24). To increase the protein yield, the P450cam 
gene was constructed into a T7-based expression vector, pET-30a (+) from Novagen, at 
the sites of NdeI and HindIII by polymerase chain reactions and ligation reactions. 
Bacteria were grown in Luria-broth supplemented with antibiotic (kanamycin, 100 μg/ml) 
for the DNA manipulation. Site-directed mutagenesis was performed by using this 
T7-based expression vector, pET-30a (+). The V247H mutant of P450cam was prepared 
with the 5’-sense oligonucleotide 5’- CTG TTA CTG CAT GGC GGC CTG GAT-3’ 
coding for LLLHGGLD. The reconstituted plasmids of both wild type and V247H 
mutant were transformed into E. coli strain NovaBlue and verified by DNA sequencing.  
2.3.3 Protein Expression and Purification 
    The wild type P450cam and mutant V247H were expressed in Escherichia coli 
strain Rosetta II (DE3). Cells were grown on terrific broth supplemented with 100mg/L 
of kanamycin at 37 ˚C and induced with 1mM IPTG and 1mM camphor at OD600 around 
0.8, followed by further growth at 30°C for another 18h prior to harvesting cells. As for 
the mutant, the addition of δ-aminolevulinic acid to the growth media is necessitated to 
facilitate holoenzyme production.  
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    Cells were lysed at 4°C in 50 mM Tris-HCl buffer at pH 7.4 containing 50 mM KCl, 
0.5 mM DTT, 1 mM camphor, 1 mM EDTA, 200 μM PMSF, 40 U/ml Dnase I, 3 U/ml 
Rnase A, and lysozyme. Following sonication and centrifugation, the lysate were 
concentrated by Amicon cell with 30,000 Da cut-off ultrafiltration membrane. The 
protein solution was applied onto a fast flow DEAE Sepharose column (50 ml) 
equilibrated with 50 mM Tris-HCl buffer (pH 7.4). After initial elution, the column was 
eluted with a linear 0-0.5 M KCl gradient in the same buffer. The red fractions containing 
the ~45 kDa proteins were pooled for further purification by size exclusion 
chromatography. Sephadex G-75 matrix (500 ml) was used for the gel filtration and the 
buffer used was 100 mM potassium phosphate containing 1mM camphor at pH 7.4. 
Substrate-free WT P450cam and its mutant were prepared by dialyzing the protein 
samples against phosphate buffer without camphor, followed by centrifugation with a 
microconcentrator (Centricon-30). Unless otherwise specified, all the steps in the protein 
purification were performed at 4 °C. 
    The Rz values of pure wild-type P450cam and V247H mutant were over 1.4 and 1.3 
respectively. The protein concentration was determined using the Soret extinction 
coefficient determined by the pyridine hemochrome method following the standard 
protocol (25, 26). The extinction coefficients for the camphor bound WT at 392 nm and 
mutant enzyme at 416 nm were 102 and 115 mM-1cm-1 respectively. These values were 
found to be 115 and 116 mM-1cm-1 for the camphor-free forms of the WT and mutant 
enzyme at 418 nm. 
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2.3.4 Spectroscopic characterization 
    Optical characterization of the wild type P450cam and its mutant was performed at 
room temperature on a Cary 300 spectrophotometer (Varian). The ferrous proteins were 
prepared by the addition of an excess amount of sodium dithionite and CO adducts were 
obtained by CO gas bubbling. The buffer used for the absorption measurements was 
100mM potassium phosphate buffer with 1mM camphor at pH 7.4.  
    CD spectra were measured on a JASCO J-815 spectrometer at room temperature. 
The secondary-structure spectral region (200-260 nm) of the spectra was recorded in a 
quartz cuvette of 1 mm path length using about 2 μM enzyme. As for the 
tertiary-structure spectral region (260-650 nm), it was recorded using about 20 μM 
enzyme in a quartz cuvette of 1cm path length with or without camphor. 
    For resonance Raman data collection, the wild-type P450 and V247H mutant were 
prepared in a septum-sealed, cylindrical quartz cell. Samples were reduced to the ferrous 
form by first flushing the sample with argon and then injecting a molar excess of buffered 
sodium dithionite solution. The rotating sample cell was irradiated with 4 mW of 413.1 
nm laser light using a mixed krypton/argon ion laser (Spectra Physics, Beamlok 2060). 
The spectral acquisition time was 5 min. The scattered light was collected at right angles 
to the incident beam and focused onto the entrance slit (125 μm) of a 0.8 m spectrograph, 
where it was dispersed by a 600 groove/mm grating and detected by a liquid-N2-cooled 
CCD camera (Horiba-JY). Spectral calibration was performed against the lines of 
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mercury. UV-vis spectra of each sample were collected before and after each RR 
measurement to ensure the sample integrity. 
    Proton nuclear magnetic resonance (1H NMR) spectra for the cyanide-bound 
proteins were recorded at 298 K on a Bruker Avance 600 (Ultrashield) spectrometer 
operating at a proton frequency of 599.97 MHz. Protein samples for NMR experiments 
were prepared in D2O buffer solutions containing 100 mM potassium phosphate at pH 7.4, 
by at least four isotope exchanges of the protein solution in H2O with D2O buffer. The 
isotope exchanges were carried out in a microconcentrator (Centricon-30) at 4 °C. All 
NMR samples contained more than 2 mM protein and the cyanide adducts of the protein 
were prepared by the addition of a 10-fold to 20-fold molar excess of cyanide from a 
freshly made 1M stock solution of KCN in 99.9% D2O. The residual solvent signal was 
suppressed with presaturation during relaxation delay. Chemical shift values were 
referenced to the residual HDO signal at 4.76 ppm.  
    Phase-sensitive NOESY spectra for the cyanide-bound derivatives of P450cam and 
its V247H mutant were acquired with mixing times ranging from 1.5 to 25 ms. Typical 
NOESY spectra were collected with 256 experiments in the F1 dimension using the 
hypercomplex method (27). In general, 1600-2000 scans were accumulated for each F1 
experiment, which was acquired with 4096 complex points in the F2 dimension over a 
spectral width of 27 or 60 kHz. The residual solvent signal in all NOESY experiments 
was suppressed using a 200-ms presaturation with a weak decoupler power.  
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    All the spectroscopic experiments were done with freshly prepared samples in 
100mM potassium phosphate buffer (pH 7.4). 
2.3.5 Redox measurements 
    The electrochemical measurements of wild type P450cam and V247H mutant were 
performed with a CHI 660 electrochemical analyzer (CH Instruments) at room 
temperature by using a conventional three electrode cell, with a glassy carbon (GC) 
electrode as the working electrode, platinum wire as counter electrode and Ag/AgCl 
electrode as the reference electrode. The carbon electrode has been modified with 
single-walled carbon nanotubes (SWCNT). The preparation of the SWCNTs was carried 
out as reported (28) and SWCNT suspension was cast onto the electrode and dried under 
infrared lamp. The SWCNT modified electrode is electrochemically activated by cyclical 
scanning between -1.0 and +1.5V at a scan rate of 1 V/sec for 2 minutes to improve the 
sensitivity of the electrode. The redox potentials of P450camV247H mutant and the wild 
type protein were obtained and normalized with the reference to NHE. 
2.3.6 Peroxidase activity 
    The peroxidation activity of the V247H mutant was measured by using 
2,2’-azino-bis-3-ethy-benzthiazoline-6-sulfonic acid (ABTS) as the electron donor and 
hydrogen peroxide as the sole oxidant (29). The reaction was initiated by the addition of 
H2O2 (3.3mM) into the reaction solution of enzyme (2μM) and ABTS (9.1 mM) in 
100mM potassium buffer from pH 5.0 to pH 7.4. Wild type P450cam and 
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chloroperoxidase were also examined at pH 5.0. Chloroperoxidase from Caldariomyces 
fumago was prepared in our own lab, and the Rz value of the protein used in this assay 
was over 1.4. The peroxidase activity was monitored at 405 nm, and the initial rate of 
oxidized ABTS product formation was used to calculate the activity. 
 
2.4 RESULTS 
2.4.1 UV-visible Spectroscopy study 
  The UV-vis spectra for the ferric, ferrous, and ferrous-CO forms of V247H mutant 
were obtained to examine the coordination structure of the heme iron both in the absence 
and presence of camphor (Fig. 2.2A and 2.2B). The substrate-free V247H exhibited 
essentially identical spectra to that of the wild type enzyme. However, the camphor 
binding was perturbed in this mutant as compared to that in wild type according to the 
optical characterizations. Instead of having the Soret band shifted from 418 nm to 392 nm 
upon camphor binding, which is characteristic of the conversion of low-spin to high-spin 
Fe (III), the mutant only displayed a 2 nm blue shift from 418 nm to 416 nm. Therefore, 
the substrate-bound V247H mutant remained predominantly in the six-coordinate, 
low-spin ferric iron state, similarly as reported in the G248E mutant of cytochrome 
P450cam (30). The shape of the Soret band of camphor-bound V247H was also different 
from that of the camphor-free protein, with less symmetry and a less prominent δ-band 
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Figure 2.2. UV-vis spectra of P450camV247H in various oxidation states: (A) camphor-free and 
(B) camphor-bound forms in 100mM phosphate buffer (pH7.4) at room temperature. 
 
 
A 
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feature at around 360nm, which is an indication of a sixth water ligand bound to the heme 
iron. Otherwise, there were only very small differences in the visible absorption bands 
(Table 2.1).   
 
Table 2.1. Wavelength and extinction coefficients of absorption maxima for wild type and 
V247H mutant of cytochrome P450cam 
 
Protein  Oxidation state Soret (nm) -band (nm) Visible (nm) 
Fe3+ 418 (392) 360 535，569 
Fe2+ 408  540 
WTP450 
(camphor-free) 
Fe2+-CO 446  550 
Fe3+ 418 (ε=116) 361 537，569 
Fe2+ 409  540 
V247H  
camphor-free 
Fe2+-CO 447  548 
Fe3+  416 (ε=115) 355 534, 569 
Fe2+ 409  542 
V247H  
camphor-bound 
Fe2+-CO 447  550 
 
    It is worth mentioning that for both camphor-free and camphor-bound samples, the 
ferrous complexes displayed the Soret maximum initially at approximately 412nm upon 
reduction, but the addition of more sodium dithionite or mixing for a longer time period 
led to the Soret band shifting to 409nm. That could be an indication of the changed (most 
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likely increased) electron density on the thiolate in the reduced state (31). The CO-bound 
form of V247H showed a Soret maximum at 447nm, which supports the presence of an 
intact iron-sulfur coordination in this mutant (32). In addition, the ligand binding activity 
of the V247H showed very similar results compared with that of wild type. For example, 
the KCN binding of V247H mutant displayed about a 24 nm red shift of the Soret band to 
440 nm (Fig. 2.3), almost identical to that of the WT P450cam (33).  
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Figure 2.3. UV spectra of P450camV247H and its KCN bound complex. The enzyme 
concentration employed was ~4μM, and 10μl of 1M KCN was added to the enzyme.  
 
2.4.2 Circular Dichrosim spectroscopy study 
    Multi-wavelength CD studies of the wild type and V247H mutant P450cam were 
carried out to investigate the effect of the distal residue substitution on the conformational  
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Figure 2.4. Far-UV CD (A) and visible CD (B) spectra of substrate-bound forms of the WT and 
V247H mutant of cytochrome P450cam.  
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properties of the enzyme. As shown in Fig. 2.4 A, the far-UV CD bands from 200-260 nm, 
which provide information on the secondary-structural features of the proteins, showed 
no significant difference between the wild type and the mutant, suggesting that the 
mutation of the valine residue had no detectable effect on the secondary structure of the 
protein. However, in the near-UV-visible CD region (300-650 nm), the camphor-bound 
V247H mutant displayed rather different spectra in its ferric form from those of the wild 
type (Fig. 2.4 B). This was consistent with the result of optical absorption measurement 
that exhibited similar properties with the substrate-free wild type protein.  
2.4.3 Resonance Raman Spectroscopy study 
  To examine the heme environment and the iron spin and ligation state of wild type 
P450cam and V247H mutant, we obtained resonance Raman spectra in the absence and 
presence of camphor. For the camphor-free ferric species, both wild type and V247H 
mutant displayed a strong oxidation state marker band υ4 at around 1370 cm-1 typical of 
ferric (Fe3+) heme (Fig. 2.5A). The heme core-size marker bands υ3 and υ2 appeared at 
approximately 1500 and 1580 cm-1, respectively for the camphor-free samples, indicating 
a six-coordinate (6C), low-spin (LS) heme iron (34-36). For the camphor-bound proteins, 
the V247H mutant showed a different pattern from the wild type. Whereas the wild type 
displayed the υ3 and υ2 bands at 1486 and 1568 cm-1, indicative of five-coordinate (5C), 
high-spin (HS) heme iron component, the V247H displayed peaks at 1499 and 1581 cm-1,  
consistent with a 6C-LS complex, similar to the camphor-free samples. The RR spectra of 
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ferrous P450cam and V247H with camphor bound showed a υ4 band at 1344 cm-1, 
consistent with thiolate proximal ligation (Fig. 2.5B) (37). The υ3 and υ2 band positions of 
these two samples at 1465 cm-1 and 1562 cm-1 confirmed that the ferrous forms of both 
wild type and mutant complexes were 5C-HS. However, the ferrous forms of 
substrate-free wild type and mutant proteins displayed a different spectral pattern from 
the camphor-bound forms. Most notably, the υ4 band appeared at 1358 instead of 1344 
cm-1, indicating a loss of or modulation of the proximal thiolate ligation. However, for the 
wild type, there was a 1344 cm-1 shoulder of the υ4 band, indicating that a weak 
population of thiolate proximal ligand was retained. 
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Figure 2.5. Resonance Raman spectra of (A) ferric and (B) ferrous wild-type P450 and 
P450V247H mutant with and without camphor binding. The excitation wavelength (λex ) was 
413.1nm. The spectra of P450 and V247H samples in the presence and absence of 1mM camphor 
are shown. 
 
2.4.4 NMR Spectroscopic study 
    Figure 2.6 showed the 1D proton NMR spectra of ferric low spin, cyanide-bound 
complexes of both wild type and V247H mutant of P450cam in the presence of camphor. 
The wild type P450cam exhibited almost identical results as repored in the literature, with 
two broad, fast relaxing, strongly hyperfine-shifted peaks at 33.1 ppm and -21.4 ppm 
respectively, indicative of the β protons from the coordinated Cys357 (38).  
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Figure 2.6 600-MHz 1H Nuclear Magnetic Resonance spectra of the low spin cyanide complexes 
of (A) wild-type P450 and (B) V247H mutant. The spectra are collected at 298K in 0.1 M 
phosphate buffer at pH7.4.  
 
    Chloroperoxidase also shows a similar spectral pattern with that of P450cam with 
two hyperfine-shifted peaks at 38.3 and -20.7 ppm, the characteristic features of protons 
in close proximity to the heme iron from Cys29 (27). The P450cam V247H mutant (Fig. 
2.6 (B)) displayed similar results, but with a slight shift compared with the wild type, 
which could be the result of conformational change caused by the substitution of the 
distal Val247. Nevertheless, the pair of peaks at 30.9 ppm and -19.8 ppm suggested the 
thiolate ligation in the V247H mutant was remained.            
2.4.5 Electrochemistry study 
Various reconstituted hemoproteins with modified heme or associated residues have 
been measured to analyze the factors that control their functions (39-41). However, the  
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Figure 2.7 Cyclic voltammograms of WT P450cam and V247H mutant on a glass carbon 
electrode modified with SWNTs in the presence (A) and absence (B) of substrate camphor. 
Voltammograms were recorded between -1.0 and +1.5V at the scan rate of 1V/sec in 100mM 
phosphate buffer (pH7.4). 
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direct determination of the redox properties of heme proteins is often rendered difficult 
due to the strong adsorption of the protein onto electrode surface. The use of 
SWNT-coated carbon electrodes virtually eliminates this problem. 
    The reduction potentials for wild type P450cam were measured to be -304 and -135 
mV in the absence and presence of camphor, respectively, both of which were in good 
agreement with the reported values (42). While the formal potential for the camphor-free 
V247H mutant was observed, to be much greater than the wild type, as high as +256 mV, 
upon substrate binding the value was decreased by about 50 mV to +206 mV (Fig. 2.7). 
This suggests that the substitution of the distal valine residue with a histidine induced a 
positive shift of the Fe3+/Fe2+ redox couple that might be attributed to the conformational 
change in the distal pocket. 
2.4.6 ABTS assay   
As shown in Fig. 2.8, the V247H mutant exhibited significant peroxidase activity 
compared with the wild type protein, and its reactivity was enhanced dramatically as pH 
increased. The highest peroxidation reactivity of the V247H mutant was observed at pH 
7.4, which is the physiological optimum pH for P450cam. It displayed even higher 
peroxidase activity than CPO, and about 700-fold increase compared with the wild type 
P450cam at pH5.0.  
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Figure 2.8 ABTS assay of cytochrome P450cam, V247H mutant and CPO at different pH values. 
The peroxidase activity was monitored at 405nm in the presence of ABTS (9.1mM), enzyme 
(2µM), and H2O2 (3.3mM) in 100mM potassium phosphate buffer. The initial slope of the 
absorbance was used to calculate the peroxidase activity. 
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2.5 DISCUSSION 
    Though P450s are potentially significant enzymes for catalyzing the insertion of 
oxygen into unactivated C-H bonds, the practical application of cytochromes P450 as 
industrial biocatalysts has been greatly limited by the requirement of expensive cofactors 
and partner proteins. In this study, we converted the P450cam into an efficient peroxidase 
without the aid of any auxiliary elements by replacing the significant distal amino acid 
Val247 with a histidine residue. A distal His is found in many heme peroxidases and thus 
V247H mimics their distal environment.  
  The ABTS assay, which serves as a typical method to examine the peroxidase 
activity, was performed to test the mutant. We showed that after substitution of Val247 
with a histidine, the mutant gained significantly higher peroxidase activity driven by 
H2O2. Although in many heme peroxidases the distal histidine plays a key role in the 
formation of CpdI, a nearby arginine residue (also highly conserved) has also been 
suggested to cooperate with the histidine, thus playing an important role in assisting the 
catalytic cycle (17, 43, 44). Considering the possible contribution that a distal arginine 
might make to the peroxidase activity of V247H, we also replaced the nearby amino acid 
L244 in the distal helix with an arginine.  However this double mutant L244R/V247H 
did not show higher peroxidase activity than the single mutant under the same conditions 
of study (data not shown). Previously, the proximal Cys357 was substituted with a  
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histidine to mimic heme peroxidases, but the V247H/C357H mutant did not exhibit better 
“peroxidase” activity compared with V247H alone (45).  
    The V247H mutant of P450cam was characterized by various spectroscopic 
techniques. UV-vis spectra showed that the resting state of V247H mutant without 
camphor is a six-coordinate, low spin ferric heme complex, similar to wild type P450cam, 
which has cysteinate and H2O serving as the axial ligands. However, in addition to the 
wild type, V247H remained 6C-LS with addition of camphor. This suggests that the 
camphor-bound V247H mutant still remains predominantly in the six-coordinated, 
low-spin ferric iron state. This indicates that the camphor enters or binds to the heme 
prosthetic group differently due to the possible conformational changes caused by the 
replacement of Val247. The substituted bulkier histidine residue might sterically hinder 
the entrance of the substrate by having the imidazole group oriented in the direction of 
the heme iron. This was further confirmed with the CD spectroscopic study. Nevertheless, 
the characteristic Soret band of the ferrous-CO complex of V247H appeared at around 
450nm, suggesting that the V247H mutant maintains the proximal heme-thiolate 
coordination. The reduced form of the mutant possesses a Soret maximum at 412nm upon 
initial reduction, which probably implies increased electron density on the thiolate in the 
reduced state (46).  
    Resonance Raman spectroscopy has proven to be a powerful probe to investigate the 
heme environment, especially the coordination, spin state and axial ligations of the heme. 
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In this study, both substrate-free and substrate-bound wild type and mutant proteins were 
examined (Fig. 3.4). Overall the spectra of P450cam with camphor in different oxidation 
states agree well with previous RR results (47, 48). The RR results of the ferric forms of 
the mutant protein in the presence and absence of camphor are also consistent with the 
UV-Vis absorption data discussed earlier. 
    The υ4 band in the RR spectrum of 5C-Fe2+ heme complexes is a useful diagnostic 
marker of the identity of the proximal ligand.  RR studies of a wide variety of heme 
proteins over the years have established that 5C-Fe2+ heme complexes with histidine 
(imidazole) as proximal ligand produce a υ4 band in the 1350-1360 cm-1 region whereas 
those with a cysteine (thiolate) proximal ligand display a υ4 band in the 1340-1348 cm-1 
region (37, 49). The ferrous forms of camphor-bound wild type P450cam and V247H 
mutant display a υ4 band in the range for 5C thiolate proximal ligation. Although the UV 
absorption spectrum of the ferrous-CO complex of camphor-free V247H indicated that 
the thiolate proximal ligand is preserved, the RR spectrum of the ferrous form does not 
indicate the same based on the previously established signatures. Thus, the υ4 band is 
located at 1358 cm-1, significantly higher than the expected 1340-1348cm-1 range for 
proximal thiolate ligation (37). A υ4 peak at 1358 cm-1 was also observed for the 
camphor-free wild type protein, although in this case a shoulder was observed at ~1344 
cm-1. Evidently, in the absence of camphor, the proximal thiolate ligand is altered either 
by being fully replaced by a histidine ligand, or by being protonated or elongated.  
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Replacement of the cysteine ligand by a histidine appears unlikely because the CD data 
did not indicate any significant conformational changes upon camphor binding (Fig. 3.4 
(A)). Also, we substituted all of the histidine residues present in the distal helix with 
either glycine or alanine and this species exhibited the same RR spectroscopic features 
(see Chapter III).  Therefore it is likely that the proximal cysteine in the present case is 
protonated rather than replaced by another proximal residue.  Indeed, Sabat et al. 
recently showed that protonation of the proximal cysteine ligand in iNOS leads to similar 
RR spectroscopic features as has been traditionally ascribed to a proximal histidine ligand 
(50). 
    The electrochemistry of this mutant together with wild type P450cam has shown that 
the distal environment can regulate the redox potential of the heme iron. For 
heme-containing oxygenases and peroxidases, the “push-pull” mechanism has been 
proposed where the generation of Cpd I is facilitated by an anionic proximal ligand 
and/or positive polar distal residues (51). In peroxidases like horseradish peroxidase or 
cytochorme c peroxidase, the “push” effect is provided by the proximal histidine and 
“pull” effect is mainly provided by the distal histidine that serves as a general acid–base 
catalyst to generate and stabilize the Cpd I (16, 52). For P450cam, since it lacks the distal 
residue that could promote the heterolytic O-O bond cleavage, the strong “push” effect 
from the proximal thiolate axial ligand is proposed to be responsive for the O–O bond 
heterolysis. It has also been suggested that the total charge near the heme could be 
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important for the heme redox potential. In the V247H mutant of P450cam, the redox 
potential was greatly increased, over 300 mV higher compared with that of the wild type. 
The increased redox potential of the V247H mutant clearly indicated the enhanced “pull" 
effect because of the introduction of the distal hisitine residue which would increase the 
total charge near the heme prosthetic group and facilitate the generation of Cpd I.  
    In summary, we have shown that the substitution of Val247 in the distal helix with a 
hydrophilic histidine residue, which is highly conserved in many heme peroxidases, has 
successfully converted P450cam into an efficient self-sufficient H2O2-driven peroxidase, 
with the thiolate ligation intact in the proximal side.  
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 CHAPTER III. ENIGNEERING CYTOCHROME P450 INTO P420 WITH 
CATALYTIC ACTIVITIES 
 
3.1 SUMMARY 
In an effort to engineer cytochrome P450cam into a self-sufficient biocatalyst, key 
structural components within the heme active site of P450cam and chloroperoxidase 
(CPO) were evaluated and the P450cam L246K mutant was constructed. L246K works as 
a self-sufficient peroxidase demonstrating the importance of polarity of the distal heme 
environment in regulating the catalytic property of P450cam. The similar UV-vis and 
resonance Raman (RR) spectra of ferric L246K and substrate-free ferric P450cam 
support a hexacoordinate, low-spin heme with thiolate ligation in this form of the mutant. 
Surprisingly, the reduced L246K and its CO complex display spectral properties similar 
to those of the inactivated species of P450cam (P420), suggesting the proximal ligand of 
L246K was changed or modified during reduction and CO binding. Contrary to what has 
been generally thought, formation of a myoglobin-like heme structure in L246K via 
histidine coordination is ruled out by the expression of a P450cam mutant (L246K-3H, 
H352G/H355G/H361A) where all three histidines located in the vicinity of the proximal 
ligand helix were replaced by glycine or alanine. On the basis of the spectral similarities 
and functional differences among L246K, the native P450cam, and the inactive P420, it is 
proposed that upon reduction and CO binding, the proximal cysteine ligand of P420 
becomes protonated due to harsh conditions employed in its preparation while the 
proximal ligand of L246K retains the parent protein’s thiolate character but with a longer 
Fe-S bond due to conformational changes induced by the mutation. 
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3.2 INTRODUCTION 
    The cytochromes P450 are a ubiquitous class of heme-containing monooxygenases 
named for their characteristic optical absorption maximum near 450 nm upon reduction 
in the presence of carbon monoxide (1). They catalyze a variety of difficult chemical 
transformations with high specificity and selectivity under physiological conditions, 
making them attractive candidates for large-scale production of fine chemicals and 
pharmaceuticals that are difficult to synthesize with standard organic chemistry (2-4). 
    Cytochrome P450cam (CYP101) from Pseudomonas putida catalyzes the 
hydroxylation of camphor and has been extensively studied as the prototype of P450 
monooxygenases because of its solubility, availability and extensive mechanistic and 
structural characterizations. It was the first to be characterized by crystallographic 
techniques among P450 enzymes (5). Previous study has shown that the resting state of 
P450cam is a predominately low spin Fe (III) porphyrin with water cluster occupying the 
sixth coordination position, upon substrate binding the water is replaced by the substrate 
camphor and the complex becomes high spin followed by reduction to Fe (II) and 
subsequent binding of O2 (6).  
    The P450s and chloroperoxidase (CPO) from Caldariomyces fumago are distinct 
from most heme proteins in possessing a deprotonated cysteine residue at the proximal 
side serving as the axial ligand to the heme iron (Fig. 3.1) (7-9). The role of axial-thiolate 
ligation in P450s has been widely studied and the thiolate ligand is suggested to serve as 
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a strong internal electron donor, facilitating the heterolytic cleavage of the dioxygen bond 
to generate the activated iron (IV)-oxo species known as Cpd I (10, 11). Also the 
presence of the cysteinate thiolate proximal heme iron ligand is believed to be 
responsible for the red-shift of the Soret absorption band at 450nm. Although P450s and 
CPO share similar metal binding sites, their heme environments are quite different in 
terms of polarity (12). The active site of P450 is highly hydrophobic in nature with the 
lack of obvious acid-base catalytic residues in close proximity to the oxygen binding 
pocket, while CPO has evolved a more polar distal heme pocket analogous to that of the 
hydro-peroxidases (13). Another dissimilarity between P450cam and CPO is that CPO 
only needs hydrogen peroxide to be catalytically active, while P450cam requires 
dioxygen, cofactor NADH and two electron-transfer proteins—putidaredoxin reductase 
and putidaredoxin which are known as the “physiological partners” (14). These 
requirements for activity are believed to be the major factors that hinder the application 
of P450s in biotechnological processes. The goal of this study is to understand the 
structure-functional relationships in hemoproteins and to investigate the feasibility of 
converting P450cam to an active catalyst without cofactors and explore the correlation 
and possible conversion between P450s and peroxidases (such as CPO).  
    Most P450 enzymes would undergo a universal denaturing transition to a stable but 
inactive species known as P420s because the absorption maximum of the resulting 
FeII-CO complex is at 420 nm rather than at 450 nm as is characteristic of P450 (15). 
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Cytochrome P420 could be formed from all known types of P450 by numerous chemical 
and physical techniques, such as incubation in organic solvents (16), exposure to high 
temperature, pressure (17, 18), neutral salts (19), or to very low and high pH buffer (20). 
P420 can sometimes, depending on how it is prepared, be converted back to P450 by 
incubation with thiols, spermine, dimethyl sulfoxide, polyols, and native substrates (16, 
22-25) . Therefore, knowledge about the structural relationship between the inactive P420 
and the native P450 is of paramount importance to our understanding of the catalytic 
activity and the nature of the putative transient intermediates involved in the catalytic 
cycle of P450 enzymes. Furthermore, the structural alterations that occur during the 
conversion of P450 to P420 will not only shed light on the conformational modification 
in many hemoprotein variants with thiolate axial ligands, but also greatly help us in the 
rational design of self sufficient P450 mutants with enhanced activity and stability. 
    In fact, there are some other P420 forms of the heme-thiolate proteins besides P450. 
As a member of P450 family, inducible nitric oxide synthase (iNOS) possesses a 
negatively charged thiolate ligand from a deprotonated cysteine residue proximal to the 
heme iron (26). Like other P450 proteins, the reduced iNOS exhibits the absorption Soret 
band at around 450nm upon CO binding (iNOSP450), which can spontaneously convert 
to an inactive species like “P420” (iNOSP420) with the Soret band at around 420nm 
(27-30). The spectroscopic studies have shown that the iNOSP420 species is inactivated 
by protonation of the proximal thiolate ligand to a neutral thiol, instead of by ligand 
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Figure 3.1 Heme environmental structure of ferric cytochrome P450cam (A) and 
chloroperoxidase (CPO: B): the heme (yellow), camphor (gray) and some selected residues 
including distal Leu246 (salmon) in P450cam are shown. The figures were generated from the 
crystal data (PDB code 2CPP and 1CPO) using PYMOL (5, 21). 
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switching (e.g. to a histidine) (31). The iNOSP450 to iNOSP420 transition is controlled 
by the conformational state of the enzyme. In addition chloroperoxidase, under alkaline 
conditions, could also undergo a denaturating transition to an inactive species that has a 
spectrum essentially identical to that of cytochrome P420, and is named C420 (32). 
Although the conversion of CPO to C420 can be stopped at any point by lowering the pH, 
it is not likely to convert C420 back to native CPO by adjusting the complex to lower pH 
values or by adding natural sulfhydryl compounds such as mercaptides (33). The heme 
iron oxidation state has been suggested to influence the transition to C420 which triggers 
the conformational change. In ferric C420, the proximal ligand C29 appears at least 
partially retained in a thiolate/imidazole coordination sphere. However the ferrous C420 
loses the thiolate ligand and has a bis-histidine coordination structure instead. Upon CO 
binding, one of the axial histidine liagnds remains trans to the carbon monoxide (32). 
    Although many physical and chemical methods have been employed to investigate 
the structural features of P420 and its counterparts in iNOS and CPO, the structural 
relationship between P450 and P420 remains controversial (22, 34-36). Postulation 
concerning the structure of P420 has been focused on the nature of the proximal heme 
iron ligand. In particular, it has been suggested that a conformational change results in 
replacement of the thiolate ligand by histidine or exogenous ligand, yielding a myoglobin 
(Mb)-like heme coordination structure (36-38). Alternatively, theoretical calculations and 
recent studies with Mb H93G cavity mutant have indicated that the proximal thiolate may 
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be protonated, resulting in a weaker thiol ligand (39, 40), or that the Fe-S bond might be 
weakened by lengthening (41). Unfortunately, there is little experimental evidence in the 
literature to distinguish these hypotheses (35, 42). Therefore, it is desirable to make a 
P450 variant that does not need harsh physical and chemical treatment but displays 
P420-like spectral features. 
    In an effort to engineer P450cam into a self sufficient catalyst, we designed several 
mutants focused on modulating the polarity of the distal heme environment. As predicted 
by the structural comparison of P450 with most heme peroxidases, introducing polar 
residues to the heme distal environment indeed improved the catalytic efficiency of P450 
dramatically. First, multiple mutations were carried out in P450cam to replace the 
hydrophobic amino acids in the distal side of the heme group with polar amino acids. The 
P450 variant was named as P450H with the substitutions of L244K, L245K, L246K, 
L250K, T252H, V253A and V254R. The spectroscopic studies of P450H showed 
P420-like properties in its ferrous and ferrous-CO complexes. To elucidate which one or 
ones of the nonpolar residues in the distal pocket induced such transition, single mutation 
and multiple mutations were performed. It turned out that the L246K mutant of P450 was 
the first example that demonstrated typical spectral features of P420s but acted as a 
self-sufficient catalyst. Through the process, the introduction of polar residues to the 
heme distal environment indeed improved the catalytic efficiency of P450 dramatically. 
More significantly, structural and biochemical studies of this P420-P450 hybrid allowed 
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us to discern the nature of the proximal heme iron ligand in the active P450 and the 
inactive P420 species. 
 
3.3 EXPERIMENTAL PROCEDURES 
3.3.1 Site-directed mutagenesis and protein expression.  
    The pUS200 plasmid used in this work, containing a 1578-bp CAM plasmid 
fragment of Pseudomonas putida (ATCC 17453), was subcloned into the PstI and HindIII 
sites of vector pEMBL8+. To increase the protein yield, the P450cam gene was 
constructed into pET-30a (+), a high copy number vector, at the sites of NdeI and HindIII 
by polymerase chain reactions and ligation reactions. The L246K mutant of P450cam was 
prepared with the 5’-sense oligonucleotide 5’- ATG TGT GGC CTG TTA AAG GTC 
GGC coding for MCGLLKVG. The L246K 3H mutant was obtained based on the L246K 
mutant with the 5’-sense oligonucleotide 5’- TTT GGC GGT GGC AGC GGT CTG TGC 
CTT GGC CAG GCA CTG GCC coding for FGHGSHLCLGQHLA. The primers used 
for P450H, and other mutants were listed in Appendix C. The reconstructed plasmids 
containing wild type P450cam and its P450H, L246K and L246K 3H mutants were 
transformed into E. coli strain NovaBlue and verified by DNA sequencing. Then the 
proteins were expressed in E. coli strain Rosetta II (DE3). Cells were grown on terrific 
broth supplemented with 100mg/L of kanamycin at 37 ˚C and induced with 1mM IPTG 
and 1mM camphor at OD600 around 0.8, followed by further growth at 30°C for another 
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18h prior to harvesting cells. As for the mutants, the addition of δ-aminolevulinic acid to 
the growth media is necessitated to facilitate holoenzyme production. The cells were then 
harvested and frozen at -80°C. 
3.3.2 Protein purification 
    Cells were lysed at 4°C in 50mM Tris-HCl buffer at pH 7.4 containing 50 mM KCl, 
0.5 mM DTT, 1 mM camphor (buffer A), 1 mM EDTA, 200 μM PMSF, 40 U/ml Dnase I, 
3 U/ml Rnase A, and lysozyme. Following sonication and centrifugation, the lysed cells 
were concentrated by Amicon cell with 30,000 Da cut-off ultrafiltration membrane. The 
protein solution was first applied on a fast flow DEAE Sepharose column. After initial 
elution, the column was eluted with a linear 0-0.5 M KCl gradient in the same buffer. As 
for the L246K and L246K 3H mutants, they were expressed as apo-proteins. So the 
fractions containing the ~45 kDa proteins were pooled for heme reconstitution. Hemin 
was added to the apo-protein dropwise and stirred overnight (43). After heme 
reconstitution, the protein was again applied on the fast flow DEAE Sepharose column. 
The reddish fractions of correct molecular weight were pooled and concentrated using a 
Centriprep with an YM30 membrane for further purification by size exclusion 
chromatography. The buffer applied on the gel filtration was 0.1 M potassium phosphate 
buffer at pH7.4. 
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    P420 was prepared as reported by adding 30% acetone and incubate at room 
temperature for 30 minutes (16). Unless otherwise specified, all the steps in the protein 
purification were performed at 4 °C. 
3.3.3 Electronic absorption spectroscopy 
    The UV-visible spectra of the P450cam mutants were recorded on a Varian Cary 300 
Bio UV-visible spectrophotometer at room temperature. The ferrous proteins were 
prepared by the addition of excess amount of sodium dithionite and CO adducts were 
obtained by CO gas bubbling. The buffer used for the absorption measurements was 
100mM potassium phosphate buffer at pH7.4. 
3.3.4 Resonance Raman spectroscopy 
For the resonance Raman data collection, the wild-type P450 and its mutant samples 
with concentration about 50μM were prepared in a septum-sealed, cylindrical quartz cell. 
Samples were reduced to the ferrous form by first flushing the sample with argon and 
then injecting a molar excess of buffered sodium dithionite solution. The rotating sample 
cell was irradiated with 4mW of 413.1nm laser light using a mixed krypton/argon ion 
laser. The spectral acquisition time was 5 min. The scattered light was collected at right 
angles to the incident beam and focused onto the entrance slit (125μm) of a 0.8m 
spectrograph, where it was dispersed by a 600 groove/mm grating and detected by a 
liquid-N2-cooled CCD camera (Horiba-JY). Spectral calibration was performed against  
 
86 
the lines of mercury. UV-vis spectra of each sample were collected before and after each 
RR measurement to ensure the sample integrity. 
3.3.5 Peroxidase activity 
    2, 2’-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) was used as the 
substrate for the enzymatic assay of peroxidase activity of wild type P450cam, P450H, 
CPO, P420 and the P450cam L246K mutant protein. 9.1mM ABTS substrate solution 
was prepared in 50mM phosphate buffer at pH5.0. Hydrogen peroxide was added to 
initiate the reaction, and the increase of the absorbance was monitored at 405nm for 2 
min. The spectrophotometer cell holder was equipped with a magnetic stirrer and the 
incubation mixture was stirred throughout the reaction.  
 
3.4 RESULTS AND DISCUSSION 
3.4.1 Optical properties and catalytic activity of P450H  
    The P450H mutant of cytochrome P450cam, in which seven hydrophobic amino 
acids were replaced by polar residues, showed very different electronic absorption 
properties with those of the wild type in all oxidation states (Fig. 3.2). Especially, the 
ferrous-CO complex of the P450H mutant displayed the absorption maximum at 420nm 
instead of 450nm which is characteristic of P450. The blue shift of the spectrum could be 
caused by the change of polarity in the distal pocket and some distinct conformational 
alteration in the active site. To examine whether the P450H mutant with increased  
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Figure 3.2 UV-visible spectra of P450H in various oxidation states. 
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Figure 3.3 Peroxidase activities of wild type P450cam and its P450H mutant determined by 
monitoring the oxidation of ABTS at 405nm in the presence of H2O2 (3.3mM), ABTS (9.1mM), 
and enzyme (2μM). 
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polarity in distal side gained some peroxidase activities, a peroxidase assay using ABTS 
as the substrate was performed that showed greatly increased activity of P450H compared 
with that of wild type protein (Fig. 3.3). These results suggested the modified distal 
environment of P450cam induced some marked changes both structurally and 
functionally.  
 
3.4.2 UV-visible spectroscopic studies of P450L246K  
    To examine specifically which one or which ones of the seven substituted residues 
in the distal pocket caused the dramatic change, single mutation and multiple mutations 
were carried out. It turned out that the single mutant L246K exhibited quite similar 
properties with those of P450H. The identity of the mutant proteins was verified by 
SDS-PAGE. Changing L246, a non-polar residue located on the distal heme of the protein, 
to lysine, a basic and polar residue resulted in a mutant typical of ferric low spin, 
six-coordinate heme proteins as demonstrated by the electronic absorption spectra of the 
mutant (Fig. 3.4). The absorption maxima of the spectra in Figure 3.4 are essentially 
identical to those of the substrate-free wild-type P450cam and P420cam (Table 3.1), 
suggesting that the proximal heme iron ligand, Cys357, in wild-type P450cam was 
retained in the L246K mutant (34, 44). However, the electronic absorption spectra of the 
ferrous and the ferrous–CO complex of the L246K mutant displayed absorption 
maximum at 423 and 419 nm, rather than at 408 and 450 nm, respectively, expected for 
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most heme thiolate proteins. It has been generally believed that these spectral features are 
characteristics of hemoproteins with proximal histidine ligand (45).  
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Figure 3.4 UV-vis spectra of P450camL246K in various oxidation states. The inset shows a 
magnification of the spectra in the α/β band region. The enzyme concentration employed was 
4μM. 
 
However, histidine ligation in this case has been ruled out due to the following two 
considerations. First, there is no histidine in the distal pocket of P450cam (9). Second, the 
ferrous and ferrous-CO forms of the P450 L246K-3H mutant (H352G/H355G/H361A) 
where all three histidines that locate in the vicinity of the proximal helix have been 
replaced by glycine or alanine, display virtually identical optical absorption features to 
those of P420 and L246K (Table 3.1). Therefore, it is proposed that the observed 
absorption maximum at 420 nm in L246K and L246K-3H mutants as well as in P420 is 
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due to milder changes such as protonation of the proximal ligand or lengthening of the  
Fe-S bond caused by conformational changes induced by mutation or conditions used in 
the preparation of P420 rather than more drastic changes such as ligand switching.   
 
Table 3.1 Wavelength and extinction coefficients of absorption maxima for WT P450cam, P420cam, 
P450camL246K and P450camL246K 3H 
 
Protein  Soret (nm)  -band (nm) Visible (nm)  
Fe3+ 417 360 535, 569 
Fe2+ 408  540 WT P450cam 
Fe2+-CO 446   550 
Fe3+ 422 367 541, 566, 651 
Fe2+ 424  530, 558 P420cam (22) 
Fe2+-CO 420   540, 572 
Fe3+ 421  362 540 
Fe2+ 423  532, 558 P450camL246K 
Fe2+-CO 419   539, 567, 620 
Fe3+ 411 360 535, 569 
Fe2+ 423  531, 558 P450camL246K 
3H 
Fe2+-CO 420  540, 569, 621 
 
  Indeed, thiol-ligated ferrous heme-CO adducts of both synthetic heme model 
compounds and biomimetic protein models display Sort absorption maximum at 420 nm 
(39, 46) Alternatively, it has been reported that lengthening of the Fe-S bond by 0.2 Å 
could induce the optical spectral transition of ferrous-CO complex of heme thiolate 
proteins from ~450 nm to ~420 nm (34, 41). Alternatively, protonation of the native 
proximal thiolate ligand to a neutral thiol could be responsible for the P420-like spectral 
91 
pattern of both L246K and L246K-3H mutants. In fact, neutral thiol-ligated ferrous 
heme-CO adducts of both synthetic heme model compounds and biomimetic protein 
models displayed absorption maximum at 420 nm (39, 46, 47). 
3.4.3 Resonance Raman spectroscopic study 
    The resonance Raman (RR) spectra of heme proteins are characterized in the  high 
frequency region by strong porphyrin in-plane vibrational bands, which are diagnostic of 
the oxidation-, spin-, and coordination-state of the heme iron (48-50). To further examine 
the heme environment of L246K and L246K-3H mutants together with wild type 
P450cam and P420, we obtained resonance Raman spectra in various oxidation states. 
The RR spectra of all the ferric protein samples displayed a strong oxidation state marker 
band ν4 at around 1370 cm-1 that is typical for ferric (Fe3+) heme (Fig. 3.5 A). The 
camphor-bound P450cam heme core-size marker bands ν 3 and ν 2 appeared at 1486 cm-1 
and 1568 cm-1, respectively, indicating a five-coordinate (5C), high-spin (HS) heme iron 
(51-53). While for all other samples, the spectra displayed the ν 3 and ν 2 bands at around 
1500 cm-1 and 1580 cm-1, suggesting a six-coordinate (6C), low-spin (LS) heme iron 
component. Overall the camphor-free, camphor-bound P450cam and P420 RR spectra 
agree well with previous RR studies (54, 55). The spectra of both ferric L246K and 
L246K-3H closely resemble that of ferric P420, with mainly 6C-LS heme iron in each 
case (Fig. 3.5 A). 
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Figure 3.5 Resonace Raman spectra of (A) ferric and (B) ferrous wild-type P450 (in the presence 
and absence of 1mM camphor), P420, P450L246K mutant and P450L246K 3H mutant. The 
excitation wavelength (λex ) was 413.1nm.  
 
The ν4 band in the RR spectrum for 5C-Fe2+ heme complexes is a useful diagnostic 
marker of the identity of the proximal ligand. RR studies of a wide variety of heme 
proteins have shown that 5C-Fe2+ heme complexes with histidine (imidazole) as proximal 
ligand produce a ν4 band in the 1350-1360 cm-1 region whereas those with a cysteine 
(thiolate) proximal ligand display a ν4 band in the 1340-1348 cm-1 region (56, 57). The 
RR spectrum of ferrous P450cam shows a ν4 band at at 1344 cm-1 that is consistent with 
thiolate proximal ligation (Fig. 3.5B). The ν3 and ν2 band at 1465 cm-1 and 1562 cm-1 
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confirm that the ferrous P450cam complex is 5C-HS. The RR spectrum of ferrous P420 
also indicates a mainly 5C-HS complex but in contrast to P450cam the ν4 band occurs at 
1357 cm-1, which is consistent with proximal histidine ligation (Fig. 3.5B). The RR 
spectra of ferrous L246K and L246K-3H mutants are almost identical to that of P420, 
thus ruling out the possibility that the high value for the position of the ν4 band is 
associated with proximal histidine ligation in this case.  
    An alternative possibility is that for ferrous P420, L246K and L246K 3H mutants 
the proximal ligand is the protonated cysteine (neutral thiol) form (58). Assignment of the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Resonace Raman spectra of FeII–CO complexes of P450camL246K and L246K-3H 
mutants in both low frequency region (A) and high frequency region (B).  
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Fe–CO and C–O stretching modes of the FeII–CO complexes is useful because they are 
influenced by the nature of proximal ligand and the polarity of the distal pocket  
environment (59, 60). The RR spectra of the FeII–CO complex of L246K mutant in the 
high-frequency region displayed a characteristic six-coordinate low-spin pattern, with  
peaks at around 1,370 cm-1 (ν4), 1,496 cm-1 (ν3), and 1,583 cm-1 (ν2) (Fig. 3.6 B). The 
L246K-3H showed almost identical six-coordinate features, indicating that it shared very 
similar heme environment with L246K. The νFe-CO bands for both of them were both of 
them were seen at 496 cm-1. Confirmation of these assignments was provided by the 
observed shifts in the presence of 13C18O (Fig. 3.7 A). In addition, νC-O for L246K was at 
approximately 1960 cm-1 in the 12C16O–13C18O difference spectrum (Fig. 3.7 B). Relating 
the frequencies of νFe-CO and νC-O can provide valuable information about the proximal 
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Figure 3.7 Fe2+-CO - Fe2+ -13C18O difference spectra P450camL246K in both low frequency 
region (A) and high frequency region (B). 
 
ligand identity and polarity of the distal environment of hemoprtoeins (61-63). Plots of 
νFe-CO versus νC-O for a wide variety of heme-CO complexes are shown in Figure 3.8. The 
observed 500 and 1960 cm-1 paring frequency for the CO complex of L246K mutant 
placed it in the region of histidine proximal ligand and a hydrophobic distal environment 
compared with myoglobin and peroxidases. Since the proximal histidine ligand has been 
ruled out in the L246K mutant, the RR results of the CO complex could be indicative of a 
protonated thiolate proximal ligation or an elongated iron-thiolate ligand. 
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Figure 3.8 Correlation of Fe–CO and C–O stretching frequencies for different heme proteins and 
porphyrin derivatives. Lines 1 and 2 are for complexes in which the proximal ligand is thiolate 
and histidine, respectively. The open circles, open squares, and open triangles correspond to data 
are obtained for mutant and pH-variant forms of horseradish peroxidase (○), cytochrome c 
peroxidase (□), and myoglobin (∆), respectively. The corresponding filled symbols represent data 
are obtained from the wild-type proteins. The filled heart corresponds to P450L246K data 
measured in this work. This figure is adapted from (61-63). 
 
3.4.4 Catalytic activity of P450L246K 
While it still remains challenging to distinguish between a protonated neutral thiol 
and an elongated thiolate ligand in heme proteins that display abnormal spectroscopic 
properties, it is generally agreed that the deprotonation of the proximal cysteine to 
cysteinate that provides the necessary “push” effect throughout the reaction cycle is 
indispensable for the catalytic activity of all known heme thiolate proteins.(1, 7-9, 47, 64) 
Therefore, an activity assay should provide a convenient measure for the identification of  
♥
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Figure 3.9 Peroxidase activity of P450camL246K mutant, P420 and CPO determined by 
monitoring the oxidation of ABTS at 405nm in the presence of H2O2 (3.3mM), ABTS (9.1mM), 
and enzyme (2μM). 
 
the nature of the proximal ligand in these proteins. Although both P420 and L246K 
display essentially identical UV-vis spectral patterns, the proximal ligand to the heme 
iron may not necessarily be the same. The fact that P420 is devoid of any catalytic 
activity suggests a protonated cysteine as the proximal heme ligand in this inactivated 
form of P450. However, the ABTS assay of L246K has shown that the mutant is able to 
act as an efficient peroxygenase (Fig. 3.9), with comparable peroxidase activity with CPO, 
via the peroxide shunt pathway. That implies that a deprotonated cysteinate ligates 
weakly to the heme iron of the mutant with a lengthened Fe-S bond. The ability of 
L246K to oxidize ABTS, a standard peroxidase substrate, in the presence of H2O2 alone 
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strongly supports the importance of polarity of heme distal environment in regulating the 
chemistry of heme proteins as predicted by structural comparison of CPO and P450cam.  
    In conclusion, our study shows that it is possible to engineer P450cam into a 
self-sufficient biocatalyst by changing the polarity of the distal heme environment of the 
protein. Our results provide strong evidence that the inactivated form of P450 (P420) uses 
a protonated cysteine as its proximal heme iron ligand while L246K keeps the parent 
protein’s thiolate ligand but with a longer Fe-S bond due to conformational changes 
induced by the mutation. It is therefore concluded that proteins with identical spectral 
signatures do not necessarily share the same heme environment. 
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CHAPTER IV. SPECTROSCOPIC STUDY OF A NOVEL HEME IRON LIGAND 
SET IN ENGINEERED CYTOCHROME P450CAM 
 
4.1 SUMMARY 
Substitution of glycine-248, the distal residue closest to the heme iron of 
cytochrome P450cam, with a histidine leads to the formation of a mutant protein with a 
novel Cys-Fe-His ligand set. This is one of the rarest cases of His ligation in 
heme-thiolate proteins, and represents the first example observed for P450cam. The 
G248H mutant shows very unique electronic absorption properties. The ferric form of 
G248H displays a characteristic Soret band at 425 nm, while its ferrous-CO complex 
shows the distinctive absorption maximum at approximately 450 nm indicative of the 
intact Cys thiolate ligation. Surprisingly, this mutant does not bind any substrates or 
exogenous ligands and is inert toward pH changes, suggesting the replacement of the 
distal water molecule with the introduced His residue as the endogenous ligand. 
Resonance Raman and circular dichroism spectroscopy results also support this model. 
The spectrum of the ferric form of G248H displayed a six-coordinate low spin pattern. 
The spectrum of ferrous mutant showed a mixture of six-coordinate low spin and 
five-coordinate high spin, indicating that the distal His-Fe bond is weakened in the 
ferrous form. The results have also provided evidence about the nature of proximal  
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ligation of the P420 species, in which the nearby histidine is not a possible alternative for 
the heme iron ligand. 
 
4.2 INTRODUCTION 
    Cytochromes P450, a superfamily of heme b-containing monooxygenases 
distributed in all domains of life, are involved in a wide range of physiologically and 
biotechnologically significant transformations, including steroid synthesis, drug 
metabolism, xenobiotic detoxification, and molecular signaling (1-4). The P450 enzymes 
typically activate dioxygen and insert one oxygen atom into a wide variety of organic 
substrates. The catalytic versatility makes these enzymes of great interest to the 
biochemical and potentially industrial applications. The most distinctive structural feature 
of cytochromes P450 is the coordination of a deprotonated cysteine to the heme iron as 
the proximal ligand, while many other hemoproteins possess a histidine at the proximal 
side. The strong electron-releasing character of the thiolate ligand has been reported to 
serve as the “push” effect to facilitate the heterolytic O-O bond cleavage to generate the  
activated intermediate Cpd I (iron-(IV)-oxo species) (5). With a few exceptions, the 
diverse reactions catalyzed by P450s all requires an external source of reducing 
equivalents like NAD(P)H and auxiliary proteins to transfer electrons to P450. The 
requirement of expensive cofactors and the complication caused by additional proteins is 
the limitation to the application of P450s as oxygenases. Some P450s are capable of 
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accepting hydrogen peroxide or organic peroxy compound as an oxidant to catalyze 
oxygen insertion through the so-called “peroxide-shunt” pathway in the absence of 
electron transport proteins and the NAD(P)H cofactor (6-11). However, P450s are 
typically not efficient in their utilization of hydrogen peroxide, the natural substrate for 
peroxidases, as the source of oxygen atom in the monooxygenation reactions. 
    Cytochrome P450cam from Pseudomonus putida is one of the most well studied 
members in the superfamily which catalyzes the region- and stereospecific hydroxylation 
of its natural substrate d-camphor to 5-exo-hydroxy-camphor (12). A great deal of effort 
has been made to suitably engineer this enzyme by directed evolution and active site 
modification for the oxygenation of significant unnatural substrates. It is still quite 
important to understand the roles of the active-site components in the reactivity, stability, 
specificity and substrate recognition of this enzyme after its discovery for over 50 years.  
    To explore the possibility of converting the cytochrome P450cam into an efficient 
self-sufficient heme peroxidase, we attempted to modify the heme distal side elements 
which play crucial mechanistic roles and regulate the enzyme functions. In most heme 
peroxidases, the distal histidine is highly conserved in the active site and has been 
considered to serve as a general acid-base catalyst necessary for the formation of Cpd I 
by donating a proton to the Fe3+-OOH moiety to promote the heterolytic cleavage of the 
O-O bond in the peroxidase reaction cycles (13-16). It has been proposed that a 
functional nitrogen (such as the nitrogen of His42 in HRP and His52 in CcP), located at a 
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suitable distance from the heme iron, could behave as an acid-base catalyst in 
hemoproteins (13, 17). 
    Therefore, in order to probe the roles of the nonpolar amino acids in the distal helix 
and to make an efficient peroxygenase, we tried to substitute a distal residue with a 
hydrophilic histidine. Given the proximity of the Gly248 residue to the heme group in 
P450cam, it is a rational to choose this residue as the target for our purpose (Fig. 4.1). 
The Gly248 residue, serving as a hydrogen bond partner with the side chain of Thr252 
and resulting in an I-helix kink (18, 19), is conserved as a small residue (Gly or Ala) in 
many P450s. In the previous study of P450 variants with the Gly or Ala substituted by a 
carboxylate reside (Glu), the carboxylate group was reported to coordinate with the heme 
iron, resulting in a six-coordinate ferric resting state in both P450cam and P450BM3 
(20-22). Thus, Gly248 in P450cam has been chosen as a good candidate to explore the 
consequences of functional alteration of the heme distal pocket on P450 structure and 
catalysis. Surprisingly, the results of the G248H variant did not show any catalytic 
activities at all because of the novel ligate set generated with the mutation. It is 
demonstrated to contain a similar heme coordination with the P450BM3 A264H mutant 
that was reported to possess a unique Cys-Fe-His heme ligand set (23). However, the 
G248H mutant of P450cam was rather different from its parallel model in the P450BM3 
variant, especially the heme coordination in its ferrous and ferrous-CO complexes. It is 
shown for the first time that thiolate ligation remains intact without being displaced by  
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Figure 4.1 The active site structure of camphor-bound cytochrome P450cam showing the 
position of some important residues including G248. The figures were generated from the crystal 
data (PDB code 2CPP) using PYMOL (18). 
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another coordination group or deprotonated in various oxidation states either in modified 
heme-thiolate proteins or in other hemoproteins with engineered proximal thiolate 
ligation. 
    In this study various spectroscopic methods, such as electronic absorption, 
resonance Raman, and circular dichroism have been applied to investigate the heme 
coordination and ligation state of the heme active site in the G248H mutant. It has always 
been difficult to identify a ligand trans to thiolate in the absence of structural detail, but 
here we successfully presented sufficient spectroscopic results that identify axial ligand 
trans to the cysteinate in this distinctive mutant of P450cam. 
 
4.3 EXPERIMENTAL PROCEDURES 
4.3.1 Site-directed Mutagenesis 
    Site-directed mutagenesis was performed by using this T7-based expression vector, 
pET-30a (+). The G248H mutant of P450cam was prepared with the 5’-sense 
oligonucleotide 5’- TTA CTG GTC CAT GGC CTG GAT ACG-3’ coding for 
LLVHGLDT. The reconstituted plasmids of both wild type and G248H mutant were 
transformed into E. coli strain NovaBlue and verified by DNA sequencing.  
4.3.2 Protein Expression and Purification 
    The wild type P450cam and mutant G248H were expressed in Escherichia coli 
strain Rosetta II (DE3). Cells were grown on terrific broth supplemented with 100mg/L 
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of kanamycin at 37 ˚C and induced with 1mM IPTG and 1 mM camphor at OD600 around 
0.8, followed by further growth at 30 °C for another 18 h prior to harvesting cells. As for 
the mutant, the addition of δ-aminolevulinic acid to the growth media is necessitated to 
facilitate holoenzyme production.  
    Cells were then lysed at 4 °C in 50 mM Tris-HCl buffer at pH 7.4 containing 50 mM 
KCl, 0.5 mM DTT, 1 mM camphor (buffer A), 1 mM EDTA, 200 μM PMSF, 40 U/ml 
Dnase I, 3 U/ml Rnase A, and lysozyme. Following sonication and centrifugation, the 
lysed cells were concentrated by Amicon cell with 30,000 Da cut-off ultrafiltration 
membrane. The protein solution was applied on a fast flow DEAE Sepharose column 
(50ml) equilibrated with buffer A. After initial elution, the column was developed with a 
linear 0-0.5 M KCl gradient in the same buffer. The red fractions containing the ~45 kDa 
proteins were pooled for further purification by size exclusion chromatography. Sephadex 
G-75 matrix (500 ml) was used for the gel filtration and the buffer applied was 100 mM 
potassium phosphate buffer containing 1 mM camphor at pH 7.4. Substrate-free 
WTP450cam and its mutant were prepared in the same way except for no camphor was 
added during the expression and purification procedures. Unless otherwise specified, all 
the steps in the protein purification were performed at 4 °C. 
4.3.3 Spectroscopic characterization 
    Optical characterization of the wild type P450cam and its mutant was performed at 
room temperature on a Cary 300 spectrophotometer (Varian). The ferrous proteins were 
prepared by the addition of excess amount of sodium dithionite and CO adducts were 
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obtained by CO gas bubbling. The buffer used for the absorption measurements was 100 
mM potassium phosphate buffer with 1 mM camphor at pH 7.4.  
    CD spectra were measured on a JASCO J-815 spectrometer at room temperature. 
The secondary-structure region (200-260 nm) of the spectra was recorded in a quartz 
cuvette of 1mm path length using about 2 μM enzyme. As for the tertiary-structure region 
(260-650 nm), they were recorded using about 20 μM enzyme in a quartz cuvette of 1 cm 
path length with and without camphor. 
For the resonance Raman data collection, the wild-type P450 and G248H mutant 
samples (about 30 μM) were prepared in a septum-sealed, cylindrical quartz cell. 
Samples were reduced to the ferrous form by first flushing the sample with argon and 
then injecting a molar excess of buffered sodium dithionite solution. The rotating sample 
cell was irradiated with 4 mW of 413.1 nm laser light using a mixed krypton/argon ion 
laser (Spectra Physics, Beamlok 2060). The spectral acquisition time was 5 min. The 
scattered light was collected at right angles to the incident beam and focused onto the 
entrance slit (125 μm) of a 0.8 m spectrograph, where it was dispersed by a 600 
groove/mm grating and detected by a liquid-N2-cooled CCD camera (Horiba-JY). 
Spectral calibration was performed against the lines of mercury. UV-vis spectra of each 
sample were collected before and after each RR measurement to ensure the sample 
integrity. 
 
114 
4.3.4 Redox potential measurements 
    The electrochemical measurements of the G248H mutant were performed with a 
CHI 660 electrochemical analyzer (CH Instruments) at room temperature by using a 
conventional three electrode cell, with a glassy carbon (GC) electrode as the working 
electrode, platinum wire as counter electrode and Ag/AgCl electrode as the reference 
electrode. The carbon electrode has been modified with single-walled carbon nanotubes 
(SWCNT). The SWCNT modified electrode is electrochemically activated by cyclical 
scanning between -1.0 and +1.5 V at a scan rate of 1 V/sec for 2 minutes to improve the 
sensitivity of the electrode. The redox potentials of P450cam G248H mutant was 
obtained and normalized with the reference to NHE. 
 
4.4 RESULTS 
4.4.1 Protein expression and purification 
The G248H mutant of P450cam was expressed as a holoprotein with the facilitation of 
heme precursor. The Rz values of pure wild-type P450cam and G248H mutant were both 
over 1.4. The protein concentration was determined using the Soret extinction coefficient 
determined by the pyridine hemochrome method following the standard protocol (24, 25). 
The extinction coefficients for camphor-bound and camphor-free forms of the mutant 
were found to be 113 and 125 mM-1cm-1, respectively, comparing with 102 and 115 
mM-1cm-1 of the wild type protein.  
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4.4.2 UV-vis spectroscopy 
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Figure 4.2 UV-vis spectra of ferric, ferrous and ferrous-CO complexes of P450camG248H: (A) 
camphor-free; (B) camphor-bound in 100mM phosphate buffer (pH7.4) at room temperature. 
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    The UV-vis spectra of wild type P450cam and G248H mutant were recorded in all 
ferric, ferrous and ferrous carbon monoxide bound forms (Table 4.1). In contrast to the 
substrate-free wild type protein in its oxidized state that has the Soret maximum at 417 
nm, the G248H mutant exhibited a Soret band at 425 nm, red shifted by 8 nm (Fig. 4.2) 
Notably, the ferric form of the mutant displayed an almost identical spectral pattern with 
that of the wild type protein complexed with imidazole (26) and that of the P450BM3 
A264H mutant (23), indicating that the substitution of the Gly248 with a histidine residue 
similar to those proteins in these proteins. Furthermore, the UV-vis spectrum of ferric 
P450camG248H did not show any change upon any ligand or substrate binding, and is 
independent of pH change as well. However, the ferrous form of the mutant was quite 
different from the wild type and its imidazole complex. Instead of showing the Soret 
band at around 408nm upon reduction, the G248H mutant had its Soret band maximum at 
421 nm. The ferrous-CO complex of the G248H mutant retained the characteristic Soret 
band at around 450nm like the wild type P450cam, which suggested that despite the 
introduction of a sterically larger group and also a stronger ligand, the thiolate ligation to 
the heme iron in the proximal side was preserved.  
    Another distinct UV-vis spectral difference between the mutant and wild type lies in 
the spectra of their camphor-bound forms. In wild type P450cam, the Soret band shifts 
from 417 nm to 392 nm upon substrate binding, indicating the conversion of low-spin to 
high-spin Fe (III). But the camphor binding was perturbed in the mutant since there was 
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no detectable change in its camphor-bound form. Thus, in the presence of camphor, the 
G248H mutant remained predominantly in the six-coordinate low-spin Fe (III) state.  
 
Table 4.1 Wavelength and extinction coefficients of absorption maxima for wild type and G248H 
mutant of cytochrome P450cam 
 
Protein  Oxidation state  Soret (nm) -band (nm) Visible (nm) 
Fe3+ 418 (ε=115) 360 535, 569 
Fe2+ 408  540 
WTP450 
(camphor-free) 
Fe2+-CO 446  550 
Fe3+ 425 (ε=98)  360 541, 578 
Fe2+ 409  543 
WTP450 + 
Imidazole (26) 
Fe2+-CO 446  549 
Fe3+ 425 (ε=123) 359 542, 573 
Fe2+ 421  541, 568 
G248H 
(camphor-free) 
Fe2+-CO 446  545 
Fe3+  424 (ε=122) 359 542, 574 
Fe2+ 421  542, 569 
G248H 
(camphor-bound) 
Fe2+-CO 446  546 
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4.4.3 Resonance Raman Spectroscopy 
    To further examine its heme environment and the iron spin and ligation state, we 
obtained RR spectra in various oxidation and coordination states of wild type and G248H 
mutant in the absence and presence of substrate camphor. The RR spectrum of ferric 
G248H with no camphor bound was very similar with to that of the wild type, displaying 
a strong oxidation state marker band υ4 at around 1370 cm-1 that is typical of ferric (Fe3+) 
heme (Fig. 4.3 A).  The heme core-size marker bands υ3 and υ2 appeared at proximately 
1500 and 1580 cm-1, respectively for both camphor-free samples, indicating a 
six-coordinate (6C), low-spin (LS) heme iron (27-29). However for the camphor-bound 
proteins, the G248H mutant was markedly different from the wild type. The wild type 
displayed the υ3 and υ2 bands at 1486 cm-1 and 1568 cm-1, respectively, typical of high- 
spin, five-coordinate (5C), heme iron component. On the contrary, the camphor-bound 
G248H was demonstrated to be a six-coordinate low-spin complex, as indicated by the 
appearance of the υ3 and υ2 bands at 1500 and 1586 cm-1, almost identical to the camphor- 
free samples. This could be the result of an unusual axial ligation of the heme iron in the 
G248H mutant.  
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Figure 4.3 Resonance Raman spectra of (A) ferric and (B) ferrous wild-type P450 and 
P450G248H mutant with and without camphor binding. The excitation wavelength (λex ) was 
413.1nm. The spectra of P450 and G248H samples in the presence and absence of 1mM camphor 
are shown. 
 
    In the ferrous form, the mutant also showed rather different spectral pattern from 
that of the wild type in the absence and presence of camphor. The RR spectrum of the 
camphor-free ferrous G248H had a significantly broadened υ4 band at 1366 cm-1 that 
implied a six-coordinate complex and rather different from the wild type (Fig. 4.3 B).  
120 
1200 1400 1600400 600 800
WT
A: Ferrous-CO
 
 
 
Raman Shift (cm-1)
G248H
WT+cam
G248H+cam
B: Ferrous-CO
13
66
13
68
13
66
13
68
14
23
14
93
15
57 15
78
16
13
14
61
14
29
14
97
15
57 15
81
16
18
14
67
14
90
15
57 15
76
16
17
14
62
14
28
14
94
15
57 15
81
16
21
14
67
49
0
G248H+cam
WT+cam
G248H
WT
 
 
 Raman Shift (cm-1)
 
67
2
67
3
67
3
67
6
49
0
47
5
74
6
74
8
74
6
75
2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Resonance Raman spectra of ferrous-CO complexes of wild-type P450 and 
P450G248H mutant with and without camphor binding in both low frequency (A) and high 
frequency (B). The excitation wavelength (λex) was 413.1nm. The spectra of P450 and G248H 
samples in the presence and absence of 1mM camphor are shown. 
 
    Typically the υ4 band appears slightly higher (~1370 cm-1) for six-coordinate ferrous 
complexes (e.g., CO and NO complexes), which suggested that in the case of G248H the 
sixth ligand was bonded rather weakly to the heme iron. Consistent with this, a very weak 
shoulder on the low frequency edge of the υ4 band could be seen in the G248H RR 
spectrum that was the result of a small population of the five-coordinate thiolate complex. 
Compared with the camphor free protein, the camphor-bound mutant demonstrated a 
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similar spectral pattern except for the υ4 band which shifted from 1366cm-1 to 1360cm-1, 
possibly due to the interference of camphor in the His binding to the heme iron in some 
way.  
    Assignment of the Fe–CO and C–O stretching modes of the FeII–CO complexes is 
useful because they are influenced by the nature of proximal ligand (30, 31). The RR 
spectra of the FeII–CO complexes of the wild type and G248H mutant in the 
high-frequency region displayed a characteristic six-coordinate low-spin pattern, with 
peaks at about 1368 cm-1 (ν4), 1495 cm-1 (ν3), and 1580 cm-1 (ν2), respectively (Fig. 4.4 
B). The νFe-CO bands showed some difference between the camphor-free and 
camphor-bound proteins. Especially for G248H with camphor, the CO stretch at around 
500 cm-1 was missing which was possibly due to the preventive interference of the His 
ligand in the distal site, suggesting CO could only partially bind to the ferrous heme iron 
and there was still some portion of histidine ligated to the iron.  
4.4.4 Circular dichroism spectroscopy  
    To investigate the effect of the mutation on the conformational change of the protein, 
multi-wavelength CD studies of the wild type and G248H mutant of P450cam were 
carried out. The far-UV CD spectra (190-260 nm) for both substrate-free and 
substrate-bound forms of G248H mutant heme domain exhibited no obvious change 
compared with that of the wild type, with minima at 219 and 209 nm respectively, 
indicating the secondary structure was not significantly altered by the substitution of 
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G248 with a histidine. Neither did the addition of camphor have any effect on the 
secondary structure of the protein in the predominantly α-helical heme domain.  
    However, in the near-UV-visible CD region (300-650 nm), the G248H mutant 
showed rather different spectra in its resting ferric form from that of the wild type. 
Furthemore, the substrate free and substrate bound forms of the mutant were markedly 
distinct from each other. In the absence of camphor, the Soret and δ bands in the heme 
CD spectrum of wild type P450cam appeared at 410 and 353 nm in negative ellipticity 
(Fig. 4.5A). The Soret band shifted to 388nm upon substrate binding, with the δ band 
disappearing (Fig. 4.5 B). Thus, the blue shift of the Soret band of P450cam mimicked 
the optical transition in the UV-vis spectrum to some extent. However, the 
near-UV-visible CD spectrum of the substrate-free G248H heme domain has its Soret 
band at 423 nm and the addition of substrate camphor triggered dramatic change in the 
Soret band, resulting in split peaks at 405 and 436 nm, respectively. This feature of the 
substrate-bound G248H mutant was more significantly different than that of the optical 
absorption spectra.  
 
123 
300 350 400 450 500 550 600 650
-12
-8
-4
0
4
 
 WTP450cam SF
 P450camG248H SF
Wavelength (nm)
300 400 500 600
-12
-8
-4
0
4
8
 WTP450cam SB
 P450camG248H SB
Wavelength (nm)
 
 
Figure 4.5 CD spectra of both substrate-free (A) and substrate-bound (B) forms of the WT and 
G248H mutant of cytochrome P450cam.  
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4.4.5 Electrochemical study     
    Derived from Figure 4.6, the redox potential for G248H mutant was measured to be  
about -92 mV, compared with -135 mV for wild type. There was some positive shift of 
the Fe3+/Fe2+ redox couple caused by the substitution of the distal glycine with a histidine 
residue. The redox potential change could be the result of the introduction of histidine 
into the distal heme pocket which increased the total charge near the heme group and 
made it easier to be reduced.  
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Figure 4.6 Cyclic voltammograms of P450cam and P450camG248H on a glass carbon electrode 
modified with SWNTs. Voltammograms were recorded between -1.0 and +1.5V at the scan rate of 
1V/sec in 100mM phosphate buffer (pH7.4).  
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4.5 DISCUSSION AND CONCLUSION 
    This work has demonstrated an intriguing model of heme-thiolate protein with a 
histidine serving as the 6th axial ligand at the distal side of the heme group. Up to date, 
there are several proteins reported to possess such Cys-His coordination. In nature, this 
ligand set has only been seen in cystathionine β-synthase (32) and Rhodovulum 
sulfidophilum SoxAX enzyme (33). Also, a few hemoproteins have been engineered to 
introduce the distal histidine ligation or proximal cysteinate ligation in the heme pocket, 
such as the M80C variant of cytochrome c (34), A264H variant of cytochrome P450BM3 
(23), and H39C mutant of cytochrome b5 (35). But in all these cases, the proximal 
cysteinate ligation was only observed in the ferric but not the ferrous oxidation state. 
Upon reduction the proximal thiolate is either protonated or replaced by an alternative 
coordinating group except for the P450BM3 A264H mutant which was not even able to 
be completely reduced and form any significant amount of CO complex. We have 
presented here the first example of hemoprotein with a Cys-Fe-His ligand set which is 
preserved in various oxidation states.  
    In the electronic absorption spectroscopic studies, the UV-visible spectra of the 
G248H mutant of P450cam displayed features that are typical of six-coordinate, low-spin 
heme complexes in the absence of substrate. The Soret band of the camphor-free mutant 
was shown red shifted from 417 nm to 425 nm, similar to what was observed in the 
imidazole-coordinated wild type protein and cytochrome P450BM3 A264H mutant, 
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indicating the heme iron ligation is complete with distal water ligand replaced by 
histidine, a stronger field ligand. Interestingly the significant spin and coordination state 
changes that occur in wild type P450cam upon camphor binding were not observed in the 
mutant, and the UV spectra of G248H mutant in the absence and presence of camphor 
were virtually indistinguishable. This implied the substrate binding was perturbed in the 
variant, and camphor was not able to displace the axial heme ligand and alter the heme 
environment in the case of the wild type protein. Because of the complete axial ligation, 
it made the mutant unable to bind any ligands. This was confirmed by the resonance 
Raman spectroscopic spectra in which the ferric G248H variant showed LS, 6C with His 
and Cys as the distal and proximal ligand respectively, regardless of whether the substrate 
camphor is bound or not.  
    Comparing the ferrous form of the imidazole complex of wild type, the G248H 
mutant was different not only in its Soret band maximum but also in the Q band region. 
The mutant displayed two α and β bands in the ferrous form, which was strong evidence 
of six coordination of the heme iron. However as for the imidazole complex of wild type 
protein, it showed only one band like the wild type and many other hemoproteins, 
indicating the preference of a five-coordination heme upon reduction. Intriguingly, in the 
study of the P450BM3 A264H mutant, a parallel variant of G248H, the distal ligand 
remained firmly bound on reduction and CO was not able to displace the His264 ligand. 
In G248H mutant, its CO complex exhibited the characteristic Soret band at around 
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450nm as the wild type, strongly indicating the preserved thiolate ligation in its ferrous 
form. Also, the RR spectra displayed distinct features of the mutant in its ferrous and CO 
complexes. The υ4 band of the ferrous G248H shifted to 1366 and 1360 cm-1, respectively 
for the substrate-free and substrate-bound forms, which were not in the region of either 
5C cysteine proximal ligation (1340-1348 cm-1) or 5C histidine proximal ligation 
(1350-1358 cm-1) (36, 37). This suggests that upon reduction, part of the histidine ligand 
was lost, resulting in a mixture of 5C and 6C coordination. Once CO was introduced, CO 
could partially bind to ferrous heme iron, but not dominantly.  
    According to the far-UV CD spectra, the secondary structure of the protein was not 
affected by the substitution of G248 with a histidine. However, there were indeed distinct 
changes in the tertiary structure around the heme pocket in the mutant compared with that 
of the wild type. The CD spectra showed markedly in different pattern in the presence 
and absence of camphor, especially in the substrate-bound form, which implied more 
significant conformational change. Except for the shift of Soret band, a set of split peaks 
was observed, indicative of strong six-coordinate ligation. Thus the binding of camphor 
makes the distal pocket more compact like the wild type and results in a stronger 
histidine ligation to the heme iron.  
    Taken together, the data of the various spectroscopic studies have demonstrated that 
the substitution of G248 with a histidine induces conformational change in the active site, 
yeilding a histidine ligation to the heme iron and alteration of the access of the substrate 
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camphor to the heme prosthetic group. When the variant is reduced and CO is introduced, 
the proximal thiolate ligation remained intact while part of the distal histidine was 
displaced. This is quite different from other reported proteins with such Cys-Fe-His 
ligation set, whether it is naturally occurring or exogenously introduced. The thiolate 
ligand tends to be lost by protonation or displaced by another coordination group in the 
reduced form. This phenomenon has also been reported in many other hemoproteins with 
thiolate ligation in their ferric forms such as CO-sensing CooA protein (38), H93C 
mutant of myoglobin (Mb) (39), H175C mutant of cytochrome c peroxidase (40) and 
inactive forms of cytochrome P450 (P420) and chloroperoxidase (C420) (41, 42). Except 
for CooA, which has been reported that the proximal ferrous ligand switches from Cys75 
to His77, other hemoproteins has been proposed to use neutral cysteine thiol as the 
possible ligand (43) or the proximal cysteinate ligand could be replaced by a nearby 
histidine residue.  
    For instance, in the study of heme iron coordination of C420, it was suggested that 
ferric C420 appeared to retain a thiolate proximal ligand but not in its ferrous form with 
the distal histidine serving as a potential ligand to the heme iron. It has also been 
proposed in the probe of ferrous P420 that histidine ligation might be involved. All the 
hypotheses imply that histidine serves as an axial ligand to heme iron more readily than 
cysteinate in the hemoproteins. However, our results failed to support these hypotheses. 
Our study unequivocally demonstrated that the endogenous thiolate ligand is retained in 
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all oxidation states in our G248H mutant. It is evident that with both His and Cys ligated 
to the heme iron at the ferric state, it is the His rather than the Cys that would fall of up 
reduction and CO binding, suggesting the cysteinate ligation is more stable in this case, 
i.e. the iron-sulfur bond is stronger than the iron-nitrogen bond.     
    The crystal structural study of wild type P450cam complexed with imidazole has 
shown that the imidazole group was bound perpendicular to the plane of the heme (44). 
In the P450BM3 variant A264H, the angle between the plane of heme and imidazole ring 
of His-264 is almost exactly 90° and the imidazole is orientated at about 45° to the 
pyrrole nitrogens to minimize unfavorable interactions.(23) Therefore, we propose here 
that in the P450cam G248H mutant, the binding of the hisitidine ligand involves 
coordination of the imidazole group to the heme iron in a similar way to the two models 
mentioned above.  
    We conclude from the data presented in this work that the P450cam G248H mutant 
is the first model of complete axial coordination with cysteinate and histidine serving as 
the ligands to the heme iron, in which the thiolate ligation remains intact upon reduction 
and CO binding. We also propose that for hemoproteins with endogenous cysteine 
ligation, the thiolate ligand would not be easily displaced by another ligand provided by 
nearby residues or solvent and that cysteine serves as a stronger ligand than histidine. The 
study of this “locking” heme model could lead to the promising development of a 
diagnostic spectroscopic method for thiolate-ligated hemoproteins to recognize such 
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coordination when it occurs elsewhere in nature or in other pertinent engineered protein 
systems.  
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CHAPTER V. PROTEIN ENGINEERING OF MYOGLOBIN WITH THIOLATE 
PROXIMAL LIGATION 
 
5.1 SUMMARY 
Myoglobin has been used as a model in the investigations of protein folding, ligand 
binding and conformational transitions of heme-containing proteins. Many studies of 
heme-imidazole proteins including myoglobin have been carried out to replace the 
proximal axial histidine ligand with a cysteine residue to gain the heme-thiolate protein 
structural character. Although some of the protein variants achieved the iron-thiolate 
ligation in their ferric forms, the iron-thiolate ligand failed to retain upon reduction. 
Therefore, to explore the possibility of converting myoglobin to a heme-thiolate protein 
in all oxidation states, I tried to mimic the protein environment of both cytochrome 
P450cam and chloroperoxidase respectively in the proximal side of sperm whale 
myoglobin by replacing eight amino acids around the iron-histidine ligand. UV-visible 
spectroscopic studies were performed to examine the axial ligation in the wild type and 
mutant proteins of Mb. Neither the P450 mimic nor the CPO mimic showed the 
characteristic Soret absorption maxima around 450nm when reduced in the presence of 
carbon monoxide, suggesting the thiolate ligation was not reserved in the ferrous forms. 
Considering the possible interference of distal histidine as a competitive candidate ligand 
to the heme iron, the His64 was substituted with an alanine and glutamic acid based on 
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comparisons with the structure of P450 and CPO, respectively. The optical spectral 
properties showed no difference. It happened again in the further mutation by replacing 
the His 97 which is located in the proximal vicinity with an alanine.  
 
5.2 INTRODUCTION 
Myoglobin is a monomeric heme protein found mainly in muscle tissues where it 
acts as an intracellular primary storage site for oxygen by reversibly binding oxygen 
molecules (1). This protein has been the target of extensive biochemical and biophysical 
studies for many years because of its physiological importance, availability and 
simplicity compared with other bulky heme proteins. It serves as a prototype for 
elucidating the roles of critical active site residues in the interactions of hemoproteins 
with small molecules such as dioxygen, carbon monoxide, and cyanide (2-5). In 
myoglobin, there is a conserved histidine residue (His93) serving as the proximal axial 
ligand to the heme iron, anchoring the heme group in the globin, and a conserved 
hisitidine residue (His64) in the distal pocket, conferring a large measure of specificity 
for O2 (6). Both of these histidine residues are important in terms of protein structure and 
function. Quite a few studies have been dedicated to examine their roles in the active site 
of myoglobins from various sources by site-directed mutagenesis in the last few decades 
(7-11).  
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    Cysteine plays a key role as a metal ligand in metalloproteins, especially in 
heme-containing proteins. A distinctive feature of heme-thiolate proteins is a Soret 
absorption band at around 450 nm in the CO difference spectrum of the reduced forms. 
The anionic cysteinate that coordinates to the heme iron in heme-thiolate proteins has 
been claimed to serve as a strong electron donor to facilitate the heterolytic O-O bond 
cleavage and the formation of Cpd I, the highly active reaction intermediate responsible 
for the catalytic reactions (12, 13). To clarify the critical role of the anionic axial ligands 
of heme proteins on the O-O bond scission reaction and the contributions of proximal 
Cys ligation to the functional and catalytic properties of cytochrome P450 and CPO, the 
proximal histidine 93 of human myglobins and horse heart myoglobin has been replaced 
with a cysteine residue (9, 10). The Mb H93C mutants resulted in altered axial ligations 
analogous to those of P-450 or CPO. The cysteine coordination to the ferric heme iron is 
confirmed by various biophysical methods, with the mutants showing almost identical 
spectroscopic properties to those of heme-thiolate proteins. The Mb H93C mutants were 
revealed to be in the ferric high-spin, five-coordinate state with the proximal cysteine 
ligated to the heme iron (9). Therefore, it is proved that the axial ligand of the heme iron 
is responsible for the spectroscopic features of hemoproteins, which has been indicated 
by various hemoproteins and their ligand-bound complexes.  
    For catalytic activities, the cysteine must be deprotonated to cysteinate throughout 
the reaction cycle as the iron changes oxidation state from ferric to ferrous and ferryl 
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states. The role of the anionic axial ligands on the O-O bond cleavage is examined by 
reactions utilizing peroxides. The results of Mb H93C mutants showed that the thiolate 
ligand enhanced the heterolytic O-O bond scission of the oxidant. This mutant also 
displayed about a 5-fold increase in epoxidation activity (9). Although the ferric forms of 
the mutants showed iron-cysteine ligation, upon reduction of the H93C variants with 
sodium dithionite under a CO atmosphere, the CO complexes displayed a similar 
spectrum to that of wild type Mb, the typical heme-imidazole protein, with the Soret band 
at around 420 nm instead of 450 nm. Thus, it is unlikely that the cysteine thiolate remains 
as the proximal ligand to the ferrous heme iron. The spectroscopic study of the mutants 
confirms that in Mb H93C the distal histidine is coordinated to the heme iron, despite the 
suggestion of a neutral thiol serving as the proximal ligand upon reduction (10, 14). On 
the basis of the H93C single mutant, several studies have been carried out to replace the 
distal histidine with a glycine, valine or isoleucine as well. The ferric state of these 
variants closely resembled the spectroscopic properties of the corresponding ferric 
cytochrome P450. However, the ferrous and ferrous-CO complexes of these variants 
remained virtually the same as for the H93C single mutant. According to these results, it 
is apparent that while simple mutagenesis modifications of the Mb active site can mimic 
the characteristics of ferric cytochrome P450 or CPO, the reproduction of the 
spectroscopic properties of their ferrous forms would require more subtle modifications 
though, which is the ultimate goal of this study.   
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    Sperm whale myoglobin (Mb), a single-chain globin protein of 154 amino acids has 
been chosen because it reprents one of the most extensively studied heme-containing 
proteins by biochemical, biophysical and spectroscopic techniques. It was the first protein 
whose crystal structure was determined to high resolution by x-ray crystallographic 
analysis in 1960 (15). Sperm whale myoglobin is composed of eight α helices (labeled 
A-H in Fig. 5.1) that form an amphipathic pocket with the heme prosthetic group bound 
between the helices. The heme iron is coordinated to the protein via a histidine ligand 
located in the F helix at the proximal site. The majority of other heme-protein contacts 
are hydrophobic except for the two solvent- exposed propionate side chains of the heme 
group that interact electrostatically with the protein residues around the prosthetic group.   
    Figure 5.2 illustrates the active site structure of sperm whale myoglobin with 
histidine residues in both proximal and distal sides along with several important amino 
acids in the proximal helix F from Leu89 to His97, with His 93 in the middle. To 
engineer sperm whale myoglobin into a heme-thiolate protein model in various oxidation 
states, all eight proximal residues around the axial ligand were replaced by the 
corresponding amino acids in P450cam and CPO, resulting in the P450 mimic of Mb 
(MbP) and CPO mimic of Mb (MbO). Furthermore, the distal histidine was substituted 
with an alanine and glutamic acid, respectively, for MbP and MbO. Finally, as the distal 
H97 that could be a potential competitive ligand to the heme iron in the ferrous forms of 
the Mb variants was also replaced. UV-visible spectroscopic studies have been carried out 
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to examine the optical properties and structural characteristics of the generated mutants of 
sperm whale myoglobin. 
 
 
 
 
 
Figure 5.1 A ribbon diagram of the sperm whale myoglobin crystal structure showing the 
arrangement of eight α helices and the heme group (shown in yellow). This figure was generated 
from the crystal data (PDB code 1VXH) using PYMOL (6).  
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Figure 5.2 Crystal structure of sperm whale myglobin active site with some important amino 
acids around heme group (yellow) viewed from different angles. In (B) the proximal amino acids 
were colored in rainbow. The figures were generated from the crystal data (PDB code 1VXH) 
using PYMOL (1).  
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5.3 EXPERIMENTAL PROCEDURES 
5.3.1 Bacterial strains, plasmids and DNA manipulations 
    The bacterial strains used were E. coli NovaBlue and E. coli Rosetta II (DE3) from 
Novagen (Gibbstown, NJ). The used plasmid pMb122 containing wild type sperm whale 
myoglobin gene in a pUC19 vector is identical to pMb413a used by Springer et al. except 
for a correction in the coding sequence (N122D) due to a mistake in the original sequence 
(16). To increase the protein yield, the Mb gene was constructed into a T7-based 
expression vector, pET-30a (+) from Novagen, at the sites of NdeI and KpNI by 
polymerase chain reactions and ligation reactions. Bacteria were grown in Luria-broth 
supplemented with antibiotic (kanamycin 100 μg/ml) for DNA manipulation.  
5.3.3 Site-directed mutagenesis and protein expression.   
 
Table 5.1 Proximal sequence alignment of Mb and its P450 and CPO mimics 
 
Protein Proximal sequence 
WT Mb L  A  Q   S   H 9 3   A  T   K 
MbP (P450 mimic) G   S   R   L   C 9 3   L   G   Q 
MbO (CPO mimic) S   R   A  P   C 9 3   P   A  L 
   
    The proximal sequence alignment of sperm whale Mb and its P450 and CPO mimics 
is listed in Table 5.1. The MbP mutant was prepared with the 5’-sense oligonucleotide 5’- 
GGT TCT CGT CTG TGC CTG GGT CAG CAT AAG ATC CCG ATC AA coding for 
GSRLCLGQHKIPI (P450mimic). The MbO mutant was obtained with the 5’-sense 
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oligonucleotide 5’- TCT CGT GCT CCT TGC CCA GCT CTG CAT AAG ATC CCG 
ATC AA coding for SRAPCPALHKIPI. Primers used for all other Mb variants are listed 
in appendix C. The reconstituted plasmids containing Mb and the mutants were 
transformed into E. coli strain NovaBlue and verified by DNA sequencing (Macrogen, 
MD). Proteins were expressed in E. coli strain Rosetta II (DE3). Cells were grown on 
Luria broth supplemented with 100 mg/L of kanamycin at 37 ˚C and induced with 1mM 
IPTG when OD600 reashes around 1.2, followed by further growth for 4 hours prior to 
harvest. As for the mutants, the addition of δ-aminolevulinic acid to the growth media is 
necessitated to facilitate holoenzyme production. The cells were then harvested and 
frozen at -80 °C. 
5.3.4 Protein purification 
    Cells were lysed at 4°C in 25 mM Tris-HCl buffer at pH 8.0 containing 0.5 mM 
DTT, 1 mM EDTA, 200 μM PMSF, 40 U/ml Dnase I, 3 U/ml Rnase A, and lysozyme for 
overnight in a shaker. After freezing at -80°C for the second time, the cells were thawed 
again followed by centrifugation and concentration using an Amicon cell with 10,000 Da 
cut-off ultrafiltration membrane. The protein solution was first applied on a fast flow 
DEAE Sepharose column equilibrated with the 10mM Tris-HCl buffer at pH 8.2. After 
initial wash, proteins were eluted with a linear 0-0.5 M NaCl gradient in the same buffer. 
All Mb mutants were expressed as apo-proteins and converted to holoproteins via heme 
reconstitution. Typically, hemin was added to the apo-protein drop wise which was 
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mixing on a stirrer for overnight (17). After heme reconstitution, the protein sample was 
again applied onto a fast flow DEAE Sepharose column. The reddish fractions of correct 
molecular weight were pooled and concentrated using a Centriprep with an YM10 
membrane for further purification by size exclusion chromatography. The buffer used for 
gel filtration was 0.1 M potassium phosphate buffer at pH 7.0. Unless otherwise specified, 
all steps in the protein purification procedure were performed at 4 °C. 
5.3.5 Electronic absorption spectroscopy 
    The UV-visible spectra of the Mb and its mutants were recorded on a Varian Cary 
300 Bio UV-visible spectrophotometer at room temperature. The ferrous proteins were 
prepared by the addition of excess amount of sodium dithionite and CO adducts were 
obtained by CO gas bubbling. The buffer used for the absorption measurements was 100 
mM potassium phosphate buffer at pH 7.0. 
 
5.4 RESULTS AND DISCUSSION 
    There are two major groups of hemoprotein found in living organisms, namely 
“heme-thiolate proteins” and “heme-imidazole proteins”. The difference between these 
two classes of proteins is that when carbon monoxide binds to the reduced forms, 
heme-thiolate proteins usually give a characteristic optical absorption spectrum with a 
prominent Soret peak at around 450 nm, whereas the corresponding absorption spectrum 
of heme-imidazolate proteins shows a Soret peak at around 420 nm. This work intended  
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Figure 5.3. UV-visible spectra of wild type Mb (A), P450cam (B) and CPO (C) in various 
oxidation states 
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to investigate the role of proximal ligands in heme-thiolate proteins by changing the 
amino acids at the proximal side of sperm whale myoglobin, a typical heme-imidazole 
protein, to that of P450 or CPO.  
First of all, wild type myoglobin, cytochrome P450cam and CPO were expressed 
and purified according to reported procedures (18-20). Figure 5.3 showed the UV-vis 
spectroscopic results of these proteins. In agreement with the literature, the ferrous-CO 
complexes of Mb displayed Soret absorption maximum at 420 nm, while P450cam and 
CPO exhibited the Soret band at 450 nm. By changing the proximal helix residues to 
mimic those of P450 and CPO, the resulted mutants were expected to show spectral 
properties similar to such heme-thiolate proteins.  
5.4.1. Mb mutant: MbP/MbO 
    Eight amino acids, at the heme proximal side of sperm whale Mb, including His 93 
have been replaced to mimic the protein environment of cytochrome P450cam and CPO, 
respectively. The mutants were named MbP and MbO. The primers were designed as one 
containing all the mutations at the end and the other one having the gene sequence at the 
opposite direction. The PCR and self-ligation reactions were performed which directly 
produced the mutated recombinant plasmid with the facilitation of T4 polynucleotide 
kinase. Both of the mutants were over expressed in E. coli. Since they showed quite 
similar results, only the electronic absorption spectra of the P450 mimic were included. 
As shown in Fig. 5.4, the UV-vis spectra of Mb exhibited very similar results with those 
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of wild type Mb with the Soret band of the ferrous heme-CO complex at 420nm, instead 
of 450nm expected for Fe-thiolate ligation. This indicated that the thiolate sulfur might 
not be ligated to the heme iron upon reduction and CO binding. There could be other 
possible factors governing the spectral properties of the mutant, for instance the influence 
of the distal histidine. Therefore, the distal histidine was replaced by a glycine and 
glutamic acid in the P450 and CPO mimics, respectively.   
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Figure 5.4 UV-visible spectra of MbP in various oxidation states. 
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5.4.2. Mb mutant: MbP H64G/MbO H64E 
  To investigate the possible interference of the distal histidine, MbP H64G and MbO 
H64E mutants were obtained. Fig. 5.5 shows the UV-vis results of the MbP H64G mutant. 
Unexpectedly, the Soret peak of the ferrous-CO complex of this Mb mutant remained at 
around 420 nm (Table 5.2). Thus, further modifications are needed to achieve a thiolate 
proximal ligand in the Mb variant at reduced state. 
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Figure 5.5 UV-visible spectra of MbP H64G in various oxidation states. 
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Table 5.2 Wavelength and extinction coefficients of absorption maxima for P450cam, Mb, 
MbP, and MbP H64G. 
 
Protein Oxidation state Soret band (nm) Visible bands (nm) 
Fe3+ 392 (ε=102) (21) 535, 569 
Fe2+ 408 540 P450cam 
Fe2+-CO 446 550 
Fe3+ 398 (ε=91.2) (22) 516, 550, 650 
Fe2+ 408 550 CPO 
Fe2+-CO 445 550 
Fe3+ 408 (ε=184) (11) 502, 631 
Fe2+ 433 556 Mb 
Fe2+-CO 422 541, 578 
Fe3+ 407 534, 569 
Fe2+ 425 532, 559 MbP 
Fe2+-CO 421 533, 561, 619 
Fe3+ 407 537, 576 
Fe2+ 425 533, 561 MbP H64G 
Fe2+-CO 422 538, 568, 620 
 
 
5.4.3. Mb mutant: MbP H64G H97A/MbO H64E H97A 
Considering that the proximal histidine 97 is located in the helix F closely to the 
heme iron and the iron-histidine ligand (His93) (Fig. 5.2), it could be a possible 
competitor to interference the altered thiolate ligation in the proximal side of MbP H64G 
mutant. Therefore, it was replaced by an alanine, which is a good helix promoter, for both 
the P450 and CPO mimics. Unfortunately, the UV-vis results showed nothing different 
from the MbP H64G mutant (data not shown). In conclusion, the attempt to engineer 
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myoglobin with a proximal thiolate ligand that can be retained in all oxidation states to 
achieve a P450-like variant was not successful. This difficulty was also reported by 
several previous studies, in which the proximal histidine was replaced by a cysteine but 
the thiolate ligation was lost upon reduction (23-26). It is apparent that the heme-thiolate 
proteins and heme-imidazole proteins have distinct structural and functional differences 
and it would take more than just mimicking the active site residues to convert one to 
another.  
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APPENDIX A 
Sequences of P450cam and pET-30a (+) Vector 
General information  
The cytochrome P450cam protein includes 414 amino acids.  
Figure A.1 lists the amino acid sequence of full-length, wild-type cytochrome P450cam. 
Figure A.2 lists the complete nucleotide sequence of the 1578-bp PstI-Hind111 fragment, 
including the wild-type cytochrome P450cam structural gene from Pseudomonas putida, 
155 bp of 5' flanking sequence, and 175 bp of 3' DNA. 
Figure A.3 lists the nucleotide sequence of vector pET-30a (+) from Novagen.  
Figure A.4 displays a map of plasmid pET-30a (+)_P450cam, which is the pET-30a (+) 
vector with the P450cam gene cloned in. 
Figure A.5 lists the nucleotide sequence of plasmid pET-30a (+)_P450cam containing 
vector pET-30a(+) and wild-type cytochrome P450cam gene cloned into NdeI (5’-end, 
nucleotide position 1596 in the pET-30a (+) vector sequence) and HindIII (3’-end, 
nucleotide position 173 in the pET-30a (+) vector sequence). The numbering is 
correspondent to that of Figure A.5.  
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Figure A.1 Amino acid sequence of full-length of WT cytochrome P450cam. 
 
1 MTTETIQSNA NLAPLPPHVP EHLVFDFDMY NPSNLSAGVQ EAWAVLQESN 
51 VPDLVWTRCN GGHWIATRGQ LIREAYEDYR HFSSECPFIP REAGEAYDFI 
101 PTSMDPPEQR QFRALANQVV GMPVVDKLEN RIQELACSLI ESLRPQGQCN 
151 FTEDYAEPFP IRIFMLLAGL PEEDIPHLKY LTDQMTRPDG SMTFAEAKEA 
201 LYDYLIPIIE QRRQKPGTDA ISIVANGQVN GRPITSDEAK RMCGLLLVGG 
251 LDTVVNFLSF SMEFLAKSPE HRQELIERPE RIPAACEELL RRFSLVADGR 
301 ILTSDYEFHG VQLKKGDQIL LPQMLSGLDE RENACPMHVD FSRQKVSHTT 
351 FGHGSHLCLG QHLARREIIV TLKEWLTRIP DFSIAPGAQI QHKSGIVSGV 
401 QALPLVWDPA TTKAV 
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Figure A.2 Nucleotide sequence of full-length WT cytochrome P450cam from 
Pseudomonas putida (5 bp upstream of PstI site, total 1578bp). 
 
1 CTGCAGGATC GTTATCCGCT GGCCGATCTG ATCACCCAGC GTTTTTCCAT  
51 CGACGAGGCC AGCAAGGCAC TTGAACTGGT CAAGGCAGGA GCACTGATCA 
101 AACCCGTGAT CGACTCCACT CTTTAGCCAA CCCGCGTTCC AGGAGAACAA 
151 CAACAATGAC GACTGAAACC ATACAAAGCA ACGCCAATCT TGCCCCTCTG  
201 CCACCCCATG TGCCAGAGCA CCTGGTATTC GACTTCGACA TGTACAATCC  
251 GTCGAATCTG TCTGCCGGCG TGCAGGAGGC CTGGGCAGTT CTGCAAGAAT 
301 CAAACGTACC GGATCTGGTG TGGACTCGCT GCAACGGCGG ACACTGGATC  
351 GCCACTCGCG GCCAACTGAT CCGTGAGGCC TATGAAGATT ACCGCCACTT  
401 TTCCAGCGAG TGCCCGTTCA TCCCTCGTGA AGCCGGCGAA GCCTACGACT  
451 TCATTCCCAC CTCGATGGAT CCGCCCGAGC AGCGCCAGTT TCGTGCGCTG 
501 GCCAACCAAG TGGTTGGCAT GCCGGTGGTG GATAAGCTGG AGAACCGGAT 
551 CCAGGAGCTG GCCTGCTCGC TGATCGAGAG CCTGCGCCCG CAAGGACAGT 
601 GCAACTTCAC CGAGGACTAC GCCGAACCCT TCCCGATACG CATCTTCATG  
651 CTGCTCGCAG GTCTACCGGA AGAAGATATC CCGCACTTGA AATACCTAAC 
701 GGATCAGATG ACCCGTCCGG ATGGCAGCAT GACCTTCGCA GAGGCCAAGG  
751 AGGCGCTCTA CGACTATCTG ATACCGATCA TCGAGCAACG CAGGCAGAAG 
801 CCGGGAACCG ACGCTATCAG CATCGTTGCC AACGGCCAGG TCAATGGGCG 
851 ACCGATCACC AGTGACGAAG CCAAGAGGAT GTGTGGCCTG TTACTGGTCG 
901 GCGGCCTGGA TACGGTGGTC AATTTCCTCA GCTTCAGCAT GGAGTTCCTG  
951 GCCAAAAGCC CGGAGCATCG CCAGGAGCTG ATCGAGCGTC CCGAGCGTAT 
1001 TCCAGCCGCT TGCGAGGAAC TACTCCGGCG CTTCTCGCTG GTTGCCGATG 
1051 GCCGCATCCT CACCTCCGAT TACGAGTTTC ATGGCGTGCA ACTGAAGAAA 
1101 GGTGACCAGA TCCTGCTACC GCAGATGCTG TCTGGCCTGG ATGAGCGCGA 
1151 AAACGCCTGC CCGATGCACG TCGACTTCAG TCGCCAAAAG GTTTCACACA 
1201 CCACCTTTGG CCACGGCAGC CATCTGTGCC TTGGCCAGCA CCTGGCCCGC 
1251 CGGGAAATCA TCGTCACCCT CAAGGAATGG CTGACCAGGA TTCCTGACTT  
1301 CTCCATTGCC CCGGGTGCCC AGATTCAGCA CAAGAGCGGC ATCGTCAGCG 
1351 GCGTGCAGGC ACTCCCTCTG GTCTGGGATC CGGCGACTAC CAAAGCGGTA 
1401 TAAACACATG GGAGTGCGTG CTAAGTGAAC GCAAACGACA ACGTGGTCAT 
1451 CGTCGGTACC GGACTGGCTG GCGTTGAGGT CGCCTTCGGC CTGCGCGCCA 
1501 GCGGCTGGGA AGGCAATATC CGGTTGGTGG GGGATGCGAC GGTAATTCCC 
1551 CATCACCTAC CACCGCTATC CAAAGCTT 
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Figure A.3 Nucleotide sequence of vector pET-30a (+). 
 
1 ATCCGGATAT AGTTCCTCCT TTCAGCAAAA AACCCCTCAA GACCCGTTTA 
51 GAGGCCCCAA GGGGTTATGC TAGTTATTGC TCAGCGGTGG CAGCAGCCAA 
101 CTCAGCTTCC TTTCGGGCTT TGTTAGCAGC CGGATCTCAG TGGTGGTGGT 
151 GGTGGTGCTC GAGTGCGGCC GCAAGCTTGT CGACGGAGCT CGAATTCGGA 
201 TCCGATATCA GCCATGGCCT TGTCGTCGTC GTCGGTACCC AGATCTGGGC 
251 TGTCCATGTG CTGGCGTTCG AATTTAGCAG CAGCGGTTTC TTTCATACCA 
301 GAACCGCGTG GCACCAGACC AGAAGAATGA TGATGATGAT GGTGCATATG 
351 TATATCTCCT TCTTAAAGTT AAACAAAATT ATTTCTAGAG GGGAATTGTT 
401 ATCCGCTCAC AATTCCCCTA TAGTGAGTCG TATTAATTTC GCGGGATCGA 
451 GATCGATCTC GATCCTCTAC GCCGGACGCA TCGTGGCCGG CATCACCGGC 
501 GCCACAGGTG CGGTTGCTGG CGCCTATATC GCCGACATCA CCGATGGGGA 
551 AGATCGGGCT CGCCACTTCG GGCTCATGAG CGCTTGTTTC GGCGTGGGTA 
601 TGGTGGCAGG CCCCGTGGCC GGGGGACTGT TGGGCGCCAT CTCCTTGCAT 
651 GCACCATTCC TTGCGGCGGC GGTGCTCAAC GGCCTCAACC TACTACTGGG 
701 CTGCTTCCTA ATGCAGGAGT CGCATAAGGG AGAGCGTCGA GATCCCGGAC 
751 ACCATCGAAT GGCGCAAAAC CTTTCGCGGT ATGGCATGAT AGCGCCCGGA 
801 AGAGAGTCAA TTCAGGGTGG TGAATGTGAA ACCAGTAACG TTATACGATG 
851 TCGCAGAGTA TGCCGGTGTC TCTTATCAGA CCGTTTCCCG CGTGGTGAAC 
901 CAGGCCAGCC ACGTTTCTGC GAAAACGCGG GAAAAAGTGG AAGCGGCGAT 
951 GGCGGAGCTG AATTACATTC CCAACCGCGT GGCACAACAA CTGGCGGGCA 
1001 AACAGTCGTT GCTGATTGGC GTTGCCACCT CCAGTCTGGC CCTGCACGCG 
1051 CCGTCGCAAA TTGTCGCGGC GATTAAATCT CGCGCCGATC AACTGGGTGC 
1101 CAGCGTGGTG GTGTCGATGG TAGAACGAAG CGGCGTCGAA GCCTGTAAAG 
1151 CGGCGGTGCA CAATCTTCTC GCGCAACGCG TCAGTGGGCT GATCATTAAC 
1201 TATCCGCTGG ATGACCAGGA TGCCATTGCT GTGGAAGCTG CCTGCACTAA 
1251 TGTTCCGGCG TTATTTCTTG ATGTCTCTGA CCAGACACCC ATCAACAGTA 
1301 TTATTTTCTC CCATGAAGAC GGTACGCGAC TGGGCGTGGA GCATCTGGTC 
1351 GCATTGGGTC ACCAGCAAAT CGCGCTGTTA GCGGGCCCAT TAAGTTCTGT 
1401 CTCGGCGCGT CTGCGTCTGG CTGGCTGGCA TAAATATCTC ACTCGCAATC 
1451 AAATTCAGCC GATAGCGGAA CGGGAAGGCG ACTGGAGTGC CATGTCCGGT 
1501 TTTCAACAAA CCATGCAAAT GCTGAATGAG GGCATCGTTC CCACTGCGAT 
1551 GCTGGTTGCC AACGATCAGA TGGCGCTGGG CGCAATGCGC GCCATTACCG 
1601 AGTCCGGGCT GCGCGTTGGT GCGGACATCT CGGTAGTGGG ATACGACGAT 
1651 ACCGAAGACA GCTCATGTTA TATCCCGCCG TTAACCACCA TCAAACAGGA 
1701 TTTTCGCCTG CTGGGGCAAA CCAGCGTGGA CCGCTTGCTG CAACTCTCTC 
1751 AGGGCCAGGC GGTGAAGGGC AATCAGCTGT TGCCCGTCTC ACTGGTGAAA 
1801 AGAAAAACCA CCCTGGCGCC CAATACGCAA ACCGCCTCTC CCCGCGCGTT 
1851 GGCCGATTCA TTAATGCAGC TGGCACGACA GGTTTCCCGA CTGGAAAGCG 
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1901 GGCAGTGAGC GCAACGCAAT TAATGTAAGT TAGCTCACTC ATTAGGCACC 
1951 GGGATCTCGA CCGATGCCCT TGAGAGCCTT CAACCCAGTC AGCTCCTTCC 
2001 GGTGGGCGCG GGGCATGACT ATCGTCGCCG CACTTATGAC TGTCTTCTTT 
2051 ATCATGCAAC TCGTAGGACA GGTGCCGGCA GCGCTCTGGG TCATTTTCGG 
2101 CGAGGACCGC TTTCGCTGGA GCGCGACGAT GATCGGCCTG TCGCTTGCGG 
2151 TATTCGGAAT CTTGCACGCC CTCGCTCAAG CCTTCGTCAC TGGTCCCGCC 
2201 ACCAAACGTT TCGGCGAGAA GCAGGCCATT ATCGCCGGCA TGGCGGCCCC 
2251 ACGGGTGCGC ATGATCGTGC TCCTGTCGTT GAGGACCCGG CTAGGCTGGC 
2301 GGGGTTGCCT TACTGGTTAG CAGAATGAAT CACCGATACG CGAGCGAACG 
2351 TGAAGCGACT GCTGCTGCAA AACGTCTGCG ACCTGAGCAA CAACATGAAT 
2401 GGTCTTCGGT TTCCGTGTTT CGTAAAGTCT GGAAACGCGG AAGTCAGCGC 
2451 CCTGCACCAT TATGTTCCGG ATCTGCATCG CAGGATGCTG CTGGCTACCC 
2501 TGTGGAACAC CTACATCTGT ATTAACGAAG CGCTGGCATT GACCCTGAGT 
2551 GATTTTTCTC TGGTCCCGCC GCATCCATAC CGCCAGTTGT TTACCCTCAC 
2601 AACGTTCCAG TAACCGGGCA TGTTCATCAT CAGTAACCCG TATCGTGAGC 
2651 ATCCTCTCTC GTTTCATCGG TATCATTACC CCCATGAACA GAAATCCCCC 
2701 TTACACGGAG GCATCAGTGA CCAAACAGGA AAAAACCGCC CTTAACATGG 
2751 CCCGCTTTAT CAGAAGCCAG ACATTAACGC TTCTGGAGAA ACTCAACGAG 
2801 CTGGACGCGG ATGAACAGGC AGACATCTGT GAATCGCTTC ACGACCACGC 
2851 TGATGAGCTT TACCGCAGCT GCCTCGCGCG TTTCGGTGAT GACGGTGAAA 
2901 ACCTCTGACA CATGCAGCTC CCGGAGACGG TCACAGCTTG TCTGTAAGCG 
2951 GATGCCGGGA GCAGACAAGC CCGTCAGGGC GCGTCAGCGG GTGTTGGCGG 
3001 GTGTCGGGGC GCAGCCATGA CCCAGTCACG TAGCGATAGC GGAGTGTATA 
3051 CTGGCTTAAC TATGCGGCAT CAGAGCAGAT TGTACTGAGA GTGCACCATA 
3101 TATGCGGTGT GAAATACCGC ACAGATGCGT AAGGAGAAAA TACCGCATCA 
3151 GGCGCTCTTC CGCTTCCTCG CTCACTGACT CGCTGCGCTC GGTCGTTCGG 
3201 CTGCGGCGAG CGGTATCAGC TCACTCAAAG GCGGTAATAC GGTTATCCAC 
3251 AGAATCAGGG GATAACGCAG GAAAGAACAT GTGAGCAAAA GGCCAGCAAA 
3301 AGGCCAGGAA CCGTAAAAAG GCCGCGTTGC TGGCGTTTTT CCATAGGCTC 
3351 CGCCCCCCTG ACGAGCATCA CAAAAATCGA CGCTCAAGTC AGAGGTGGCG 
3401 AAACCCGACA GGACTATAAA GATACCAGGC GTTTCCCCCT GGAAGCTCCC 
3451 TCGTGCGCTC TCCTGTTCCG ACCCTGCCGC TTACCGGATA CCTGTCCGCC 
3501 TTTCTCCCTT CGGGAAGCGT GGCGCTTTCT CATAGCTCAC GCTGTAGGTA 
3551 TCTCAGTTCG GTGTAGGTCG TTCGCTCCAA GCTGGGCTGT GTGCACGAAC 
3601 CCCCCGTTCA GCCCGACCGC TGCGCCTTAT CCGGTAACTA TCGTCTTGAG 
3651 TCCAACCCGG TAAGACACGA CTTATCGCCA CTGGCAGCAG CCACTGGTAA 
3701 CAGGATTAGC AGAGCGAGGT ATGTAGGCGG TGCTACAGAG TTCTTGAAGT 
3751 GGTGGCCTAA CTACGGCTAC ACTAGAAGGA CAGTATTTGG TATCTGCGCT 
3801 CTGCTGAAGC CAGTTACCTT CGGAAAAAGA GTTGGTAGCT CTTGATCCGG 
3851 CAAACAAACC ACCGCTGGTA GCGGTGGTTT TTTTGTTTGC AAGCAGCAGA 
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3901 TTACGCGCAG AAAAAAAGGA TCTCAAGAAG ATCCTTTGAT CTTTTCTACG 
3951 GGGTCTGACG CTCAGTGGAA CGAAAACTCA CGTTAAGGGA TTTTGGTCAT 
4001 GAACAATAAA ACTGTCTGCT TACATAAACA GTAATACAAG GGGTGTTATG 
4051 AGCCATATTC AACGGGAAAC GTCTTGCTCT AGGCCGCGAT TAAATTCCAA 
4101 CATGGATGCT GATTTATATG GGTATAAATG GGCTCGCGAT AATGTCGGGC 
4151 AATCAGGTGC GACAATCTAT CGATTGTATG GGAAGCCCGA TGCGCCAGAG 
4201 TTGTTTCTGA AACATGGCAA AGGTAGCGTT GCCAATGATG TTACAGATGA 
4251 GATGGTCAGA CTAAACTGGC TGACGGAATT TATGCCTCTT CCGACCATCA 
4301 AGCATTTTAT CCGTACTCCT GATGATGCAT GGTTACTCAC CACTGCGATC 
4351 CCCGGGAAAA CAGCATTCCA GGTATTAGAA GAATATCCTG ATTCAGGTGA 
4401 AAATATTGTT GATGCGCTGG CAGTGTTCCT GCGCCGGTTG CATTCGATTC 
4451 CTGTTTGTAA TTGTCCTTTT AACAGCGATC GCGTATTTCG TCTCGCTCAG 
4501 GCGCAATCAC GAATGAATAA CGGTTTGGTT GATGCGAGTG ATTTTGATGA 
4551 CGAGCGTAAT GGCTGGCCTG TTGAACAAGT CTGGAAAGAA ATGCATAAAC 
4601 TTTTGCCATT CTCACCGGAT TCAGTCGTCA CTCATGGTGA TTTCTCACTT 
4651 GATAACCTTA TTTTTGACGA GGGGAAATTA ATAGGTTGTA TTGATGTTGG 
4701 ACGAGTCGGA ATCGCAGACC GATACCAGGA TCTTGCCATC CTATGGAACT 
4751 GCCTCGGTGA GTTTTCTCCT TCATTACAGA AACGGCTTTT TCAAAAATAT 
4801 GGTATTGATA ATCCTGATAT GAATAAATTG CAGTTTCATT TGATGCTCGA 
4851 TGAGTTTTTC TAAGAATTAA TTCATGAGCG GATACATATT TGAATGTATT 
4901 TAGAAAAATA AACAAATAGG GGTTCCGCGC ACATTTCCCC GAAAAGTGCC 
4951 ACCTGAAATT GTAAACGTTA ATATTTTGTT AAAATTCGCG TTAAATTTTT 
5001 GTTAAATCAG CTCATTTTTT AACCAATAGG CCGAAATCGG CAAAATCCCT 
5051 TATAAATCAA AAGAATAGAC CGAGATAGGG TTGAGTGTTG TTCCAGTTTG 
5101 GAACAAGAGT CCACTATTAA AGAACGTGGA CTCCAACGTC AAAGGGCGAA 
5151 AAACCGTCTA TCAGGGCGAT GGCCCACTAC GTGAACCATC ACCCTAATCA 
5201 AGTTTTTTGG GGTCGAGGTG CCGTAAAGCA CTAAATCGGA ACCCTAAAGG 
5251 GAGCCCCCGA TTTAGAGCTT GACGGGGAAA GCCGGCGAAC GTGGCGAGAA 
5301 AGGAAGGGAA GAAAGCGAAA GGAGCGGGCG CTAGGGCGCT GCAAGTGTA 
5351 GCGGTCACGC TGCGCGTAAC CACCACACCC GCCGCGCTTA ATGCGCCGCT 
5401 ACAGGGCGCG TCCCATTCGC CA 
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Figure A.4 Plasmid map of pET-30a (+)_P450cam.  
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Figure A.5 Nucleotide sequence of plasmid containing vector pET-30a(+) and WT 
cytochrome P450cam gene. (152+1426+5072=6670bp) 
 
1 ATCCGGATAT AGTTCCTCCT TTCAGCAAAA AACCCCTCAA GACCCGTTTA 
51 GAGGCCCCAA GGGGTTATGC TAGTTATTGC TCAGCGGTGG CAGCAGCCAA 
101 CTCAGCTTCC TTTCGGGCTT TGTTAGCAGC CGGATCTCAG TGGTGGTGGT 
151 GGTGGTGCTC GAGTGCGGCC GCAAGCTTTG GATAGCGGTG GTAGGTGATG 
201 GGGAATTACC GTCGCATCCC CCACCAACCG GATATTGCCT TCCCAGCCGC  
251 TGGCGCGCAG GCCGAAGGCG ACCTCAACGC CAGCCAGTCC GGTACCGACG  
301 ATGACCACGT TGTCGTTTGC GTTCACTTAG CACGCACTCC CATGTGTTTA  
351 TACCGCTTTG GTAGTCGCCG GATCCCAGAC CAGAGGGAGT GCCTGCACGC  
401 CGCTGACGAT GCCGCTCTTG TGCTGAATCT GGGCACCCGG GGCAATGGAG  
451 AAGTCAGGAA TCCTGGTCAG CCATTCCTTG AGGGTGACGA TGATTTCCCG  
501 GCGGGCCAGG TGCTGGCCAA GGCACAGATG GCTGCCGTGG CCAAAGGTGG  
551 TGTGTGAAAC CTTTTGGCGA CTGAAGTCGA CGTGCATCGG GCAGGCGTTT   
601 TCGCGCTCAT CCAGGCCAGA CAGCATCTGC GGTAGCAGGA TCTGGTCACC  
651 TTTCTTCAGT TGCACGCCAT GAAACTCGTA ATCGGAGGTG AGGATGCGGC  
701 CATCGGCAAC CAGCGAGAAG CGCCGGAGTA GTTCCTCGCA AGCGGCTGGA  
751 ATACGCTCGG GACGCTCGAT CAGCTCCTGG CGATGCTCCG GGCTTTTGGC  
801 CAGGAACTCC ATGCTGAAGC TGAGGAAATT GACCACCGTA TCCAGGCCGC  
851 CGACCAGTAA CAGGCCACAC ATCCTCTTGG CTTCGTCACT GGTGATCGGT  
901 CGCCCATTGA CCTGGCCGTT GGCAACGATG CTGATAGCGT CGGTTCCCGG  
951 CTTCTGCCTG CGTTGCTCGA TGATCGGTAT CAGATAGTC GTAGAGCGCCT  
1001 CCTTGGCCTC TGCGAAGGTC ATGCTGCCAT CCGGACGGGT CATCTGATCC  
1051 GTTAGGTATT TCAAGTGCGG GATATCTTCT TCCGGTAGAC CTGCGAGCAG  
1101 CATGAAGATG CGTATCGGGA AGGGTTCGGC GTAGTCCTCG GTGAAGTTGC  
1151 ACTGTCCTTG CGGGCGCAGG CTCTCGATCA GCGAGCAGGC CAGCTCCTGG  
1201 ATCCGGTTCT CCAGCTTATC CACCACCGGC ATGCCAACCA CTTGGTTGGC  
1251 CAGCGCACGA AACTGGCGCT GCTCGGGCGG ATCCATCGAG GTGGGAATGA  
1301 AGTCGTAGGC TTCGCCGGCT TCACGAGGGA TGAACGGGCA CTCGCTGGAA  
1351 AAGTGGCGGT AATCTTCATA GGCCTCACGG ATCAGTTGGC CGCGAGTGGC  
1401 GATCCAGTGT CCGCCGTTGC AGCGAGTCCA CACCAGATCC GGTACGTTTG  
1451 ATTCTTGCAG AACTGCCCAG GCCTCCTGCA CGCCGGCAGA CAGATTCGAC  
1501 GGATTGTACA TGTCGAAGTC GAATACCAGG TGCTCTGGCA CATGGGGTGG 
1551 CAGAGGGGCA AGATTGGCGT TGCTTTGTAT GGTTTCAGTC GTCATATGTA 
1601 TATCTCCTTC TTAAAGTTAA ACAAAATTAT TTCTAGAGGG GAATTGTTAT 
1651 CCGCTCACAA TTCCCCTATA GTGAGTCGTA TTAATTTCGC GGGATCGAGA 
1701 TCGATCTCGA TCCTCTACGC CGGACGCATC GTGGCCGGCA TCACCGGCGC 
1751 CACAGGTGCG GTTGCTGGCG CCTATATCGC CGACATCACC GATGGGGAAG 
1801 ATCGGGCTCG CCACTTCGGG CTCATGAGCG CTTGTTTCGG CGTGGGTATG 
162 
1851 GTGGCAGGCC CCGTGGCCGG GGGACTGTTG GGCGCCATCT CCTTGCATGC 
1901 ACCATTCCTT GCGGCGGCGG TGCTCAACGG CCTCAACCTA CTACTGGGCT 
1951 GCTTCCTAAT GCAGGAGTCG CATAAGGGAG AGCGTCGAGA TCCCGGACAC  
2001 CATCGAATGG CGCAAAACCT TTCGCGGTAT GGCATGATAG CGCCCGGAAG  
2051 AGAGTCAATT CAGGGTGGTG AATGTGAAAC CAGTAACGTT ATACGATGTC 
2101 GCAGAGTATG CCGGTGTCTC TTATCAGACC GTTTCCCGCG TGGTGAACCA 
2151 GGCCAGCCAC GTTTCTGCGA AAACGCGGGA AAAAGTGGAA GCGGCGATGG 
2201 CGGAGCTGAA TTACATTCCC AACCGCGTGG CACAACAACT GGCGGGCAAA 
2251 CAGTCGTTGC TGATTGGCGT TGCCACCTCC AGTCTGGCCC TGCACGCGCC 
2301 GTCGCAAATT GTCGCGGCGA TTAAATCTCG CGCCGATCAA CTGGGTGCCA 
2351 GCGTGGTGGT GTCGATGGTA GAACGAAGCG GCGTCGAAGC CTGTAAAGCG 
2401 GCGGTGCACA ATCTTCTCGC GCAACGCGTC AGTGGGCTGA TCATTAACTA 
2451 TCCGCTGGAT GACCAGGATG CCATTGCTGT GGAAGCTGCC TGCACTAATG  
2501 TTCCGGCGTT ATTTCTTGAT GTCTCTGACC AGACACCCAT CAACAGTATT 
2551 ATTTTCTCCC ATGAAGACGG TACGCGACTG GGCGTGGAGC ATCTGGTCGC 
2601 ATTGGGTCAC CAGCAAATCG CGCTGTTAGC GGGCCCATTA AGTTCTGTCT 
2651 CGGCGCGTCT GCGTCTGGCT GGCTGGCATA AATATCTCAC TCGCAATCAA 
2701 ATTCAGCCGA TAGCGGAACG GGAAGGCGAC TGGAGTGCCA TGTCCGGTTT 
2751 TCAACAAACC ATGCAAATGC TGAATGAGGG CATCGTTCCC ACTGCGATGC 
2801 TGGTTGCCAA CGATCAGATG GCGCTGGGCG CAATGCGCGC CATTACCGAG 
2851 TCCGGGCTGC GCGTTGGTGC GGACATCTCG GTAGTGGGAT ACGACGATAC 
2901 CGAAGACAGC TCATGTTATA TCCCGCCGTT AACCACCATC AAACAGGATT 
2951 TTCGCCTGCT GGGGCAAACC AGCGTGGACC GCTTGCTGCA ACTCTCTCAG 
3001 GGCCAGGCGG TGAAGGGCAA TCAGCTGTTG CCCGTCTCAC TGGTGAAAAG 
3051 AAAAACCACC CTGGCGCCCA ATACGCAAAC CGCCTCTCCC CGCGCGTTGG 
3101 CCGATTCATT AATGCAGCTG GCACGACAGG TTTCCCGACT GGAAAGCGGG 
3151 CAGTGAGCGC AACGCAATTA ATGTAAGTTA GCTCACTCAT TAGGCACCGG 
3201 GATCTCGACC GATGCCCTTG AGAGCCTTCA ACCCAGTCAG CTCCTTCCGG 
3251 TGGGCGCGGG GCATGACTAT CGTCGCCGCA CTTATGACTG TCTTCTTTAT 
3301 CATGCAACTC GTAGGACAGG TGCCGGCAGC GCTCTGGGTC ATTTTCGGCG 
3351 AGGACCGCTT TCGCTGGAGC GCGACGATGA TCGGCCTGTC GCTTGCGGTA 
3401 TTCGGAATCT TGCACGCCCT CGCTCAAGCC TTCGTCACTG GTCCCGCCAC 
3451 CAAACGTTTC GGCGAGAAGC AGGCCATTAT CGCCGGCATG GCGGCCCCAC 
3501 GGGTGCGCAT GATCGTGCTC CTGTCGTTGA GGACCCGGCT AGGCTGGCGG 
3551 GGTTGCCTTA CTGGTTAGCA GAATGAATCA CCGATACGCG AGCGAACGTG 
3601 AAGCGACTGC TGCTGCAAAA CGTCTGCGAC CTGAGCAACA ACATGAATGG 
3651 TCTTCGGTTT CCGTGTTTCG TAAAGTCTGG AAACGCGGAA GTCAGCGCCC 
3701 TGCACCATTA TGTTCCGGAT CTGCATCGCA GGATGCTGCT GGCTACCCTG 
3751 TGGAACACCT ACATCTGTAT TAACGAAGCG CTGGCATTGA CCCTGAGTGA 
3801 TTTTTCTCTG GTCCCGCCGC ATCCATACCG CCAGTTGTTT ACCCTCACAA 
163 
3851 CGTTCCAGTA ACCGGGCATG TTCATCATCA GTAACCCGTA TCGTGAGCAT 
3901 CCTCTCTCGT TTCATCGGTA TCATTACCCC CATGAACAGA AATCCCCCTT 
3951 ACACGGAGGC ATCAGTGACC AAACAGGAAA AAACCGCCCT TAACATGGCC 
4001 CGCTTTATCA GAAGCCAGAC ATTAACGCTT CTGGAGAAAC TCAACGAGCT 
4051 GGACGCGGAT GAACAGGCAG ACATCTGTGA ATCGCTTCAC GACCACGCTG 
4101 ATGAGCTTTA CCGCAGCTGC CTCGCGCGTT TCGGTGATGA CGGTGAAAAC 
4151 CTCTGACACA TGCAGCTCCC GGAGACGGTC ACAGCTTGTC TGTAAGCGGA 
4201 TGCCGGGAGC AGACAAGCCC GTCAGGGCGC GTCAGCGGGT GTTGGCGGGT 
4251 GTCGGGGCGC AGCCATGACC CAGTCACGTA GCGATAGCGG AGTGTATACT 
4301 GGCTTAACTA TGCGGCATCA GAGCAGATTG TACTGAGAGT GCACCATATA 
4351 TGCGGTGTGA AATACCGCAC AGATGCGTAA GGAGAAAATA CCGCATCAGG 
4401 CGCTCTTCCG CTTCCTCGCT CACTGACTCG CTGCGCTCGG TCGTTCGGCT 
4451 GCGGCGAGCG GTATCAGCTC ACTCAAAGGC GGTAATACGG TTATCCACAG 
4501 AATCAGGGGA TAACGCAGGA AAGAACATGT GAGCAAAAGG CCAGCAAAAG 
4551 GCCAGGAACC GTAAAAAGGC CGCGTTGCTG GCGTTTTTCC ATAGGCTCCG 
4601 CCCCCCTGAC GAGCATCACA AAAATCGACG CTCAAGTCAG AGGTGGCGAA 
4651 ACCCGACAGG ACTATAAAGA TACCAGGCGT TTCCCCCTGG AAGCTCCCTC 
4701 GTGCGCTCTC CTGTTCCGAC CCTGCCGCTT ACCGGATACC TGTCCGCCTT 
4751 TCTCCCTTCG GGAAGCGTGG CGCTTTCTCA TAGCTCACGC TGTAGGTATC 
4801 TCAGTTCGGT GTAGGTCGTT CGCTCCAAGC TGGGCTGTGT GCACGAACCC 
4851 CCCGTTCAGC CCGACCGCTG CGCCTTATCC GGTAACTATC GTCTTGAGTC 
4901 CAACCCGGTA AGACACGACT TATCGCCACT GGCAGCAGCC ACTGGTAACA 
4951 GGATTAGCAG AGCGAGGTAT GTAGGCGGTG CTACAGAGTT CTTGAAGTGG 
5001 TGGCCTAACT ACGGCTACAC TAGAAGGACA GTATTTGGTA TCTGCGCTCT 
5051 GCTGAAGCCA GTTACCTTCG GAAAAAGAGT TGGTAGCTCT TGATCCGGCA 
5101 AACAAACCAC CGCTGGTAGC GGTGGTTTTT TTGTTTGCAA GCAGCAGATT 
5151 ACGCGCAGAA AAAAAGGATC TCAAGAAGAT CCTTTGATCT TTTCTACGGG 
5201 GTCTGACGCT CAGTGGAACG AAAACTCACG TTAAGGGATT TTGGTCATGA 
5251 ACAATAAAAC TGTCTGCTTA CATAAACAGT AATACAAGGG GTGTTATGAG 
5301 CCATATTCAA CGGGAAACGT CTTGCTCTAG GCCGCGATTA AATTCCAACA 
5351 TGGATGCTGA TTTATATGGG TATAAATGGG CTCGCGATAA TGTCGGGCAA 
5401 TCAGGTGCGA CAATCTATCG ATTGTATGGG AAGCCCGATG CGCCAGAGTT 
5451 GTTTCTGAAA CATGGCAAAG GTAGCGTTGC CAATGATGTT ACAGATGAGA 
5501 TGGTCAGACT AAACTGGCTG ACGGAATTTA TGCCTCTTCC GACCATCAAG 
5551 CATTTTATCC GTACTCCTGA TGATGCATGG TTACTCACCA CTGCGATCCC 
5601 CGGGAAAACA GCATTCCAGG TATTAGAAGA ATATCCTGAT TCAGGTGAAA 
5651 ATATTGTTGA TGCGCTGGCA GTGTTCCTGC GCCGGTTGCA TTCGATTCCT 
5701 GTTTGTAATT GTCCTTTTAA CAGCGATCGC GTATTTCGTC TCGCTCAGGC 
5751 GCAATCACGA ATGAATAACG GTTTGGTTGA TGCGAGTGAT TTTGATGACG 
5801 AGCGTAATGG CTGGCCTGTT GAACAAGTCT GGAAAGAAAT GCATAAACTT 
164 
5851 TTGCCATTCT CACCGGATTC AGTCGTCACT CATGGTGATT TCTCACTTGA 
5901 TAACCTTATT TTTGACGAGG GGAAATTAAT AGGTTGTATT GATGTTGGAC 
5951 GAGTCGGAAT CGCAGACCGA TACCAGGATC TTGCCATCCT ATGGAACTGC 
6001 CTCGGTGAGT TTTCTCCTTC ATTACAGAAA CGGCTTTTTC AAAAATATGG 
6051 TATTGATAAT CCTGATATGA ATAAATTGCA GTTTCATTTG ATGCTCGATG 
6101 AGTTTTTCTA AGAATTAATT CATGAGCGGA TACATATTTG AATGTATTTA 
6151 GAAAAATAAA CAAATAGGGG TTCCGCGCAC ATTTCCCCGA AAAGTGCCAC 
6201 CTGAAATTGT AAACGTTAAT ATTTTGTTAA AATTCGCGTT AAATTTTTGT 
6251 TAAATCAGCT CATTTTTTAA CCAATAGGCC GAAATCGGCA AAATCCCTTA 
6301 TAAATCAAAA GAATAGACCG AGATAGGGTT GAGTGTTGTT CCAGTTTGGA 
6351 ACAAGAGTCC ACTATTAAAG AACGTGGACT CCAACGTCAA AGGGCGAAAA 
6401 ACCGTCTATC AGGGCGATGG CCCACTACGT GAACCATCAC CCTAATCAAG 
6451 TTTTTTGGGG TCGAGGTGCC GTAAAGCACT AAATCGGAAC CCTAAAGGGA 
6501 GCCCCCGATT TAGAGCTTGA CGGGGAAAGC CGGCGAACGT GGCGAGAAAG 
6551 GAAGGGAAGA AAGCGAAAGG AGCGGGCGCT AGGGCGCTGG CAAGTGTAGC 
6601 GGTCACGCTG CGCGTAACCA CCACACCCGC CGCGCTTAAT GCGCCGCTAC 
6651 AGGGCGCGTC CCATTCGCCA 
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APPENDIX B 
Sequences of Sperm Whale Myoglobin and pET-30a (+) Vector 
General information  
The sperm whale myoglobin includes 154 amino acids.  
Figure B.1 lists the amino acid sequence of full-length, wild-type sperm whale 
myoglobin.  
Figure B.1 lists the nucleotide sequence of the synthesized sperm whale myoglobin gene 
as designed from the amio acid sequence including the ribosome binding site. (Springer, 
B. et al, Proc Natl Acad Sci USA, 1987, 84, 8961-8965) 
Figure B.3 displays a map of plasmid pET-30a (+)_Mb, which is the pET-30a (+) vector 
with the sperm whale myoglobin gene cloned in. 
Figure B.4 lists the nucleotide sequence of plasmid pET-30a (+)_Mb containing vector 
pET-30a(+) and wild-type sperm whale myoglobin gene cloned into NdeI (5’-end, 
nucleotide position 713 in the pET-30a (+) vector sequence) and KpNI (3’-end, 
nucleotide position 238 in the pET-30a (+) vector sequence). The numbering is 
correspondent to that of Figure B.4.  
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Figure B.1 Amino acid sequence of full-length of sperm whale myoglobin (154aa). 
 
1 MVLSEGEWQL VLHVWAKVEA DVAGHGQDIL IRLFKSHPET LEKFDRFKHL 
51 KTEAEMKASE DLKKHGVTVL TALGAILKKK GHHEAELKPL AQSHATKHKI 
101 PIKYLEFISE AIIHVLHSRH PGNFGADAQG AMNKALELFR KDIAAKYKEL 
151 GYQG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B.2 Nucleotide sequence of full-length sperm whale myoglobin (507bp). 
 
1 CTGCAGATAA CTAACTAAAG GAGAACAACA ACAATGGTTC TGTCTGAAGG 
51 TGAATGGCAG CTGGTTCTGC ATGTTTGGGC TAAAGTTGAA GCTGACGTCG 
101 CTGGTCATGG TCAGGACATC TTGATTCGAC TGTTCAAATC TCATCCGGAA 
151 ACTCTGGAAA AATTCGATCG TTTCAAACAT CTGAAAACTG AAGCTGAAAT 
201 GAAAGCTTCT GAAGATCTGA AAAAACATGG TGTTACCGTG TTAACTGCCC  
251 TAGGTGCTAT CCTTAAGAAA AAAGGGCATC ATGAAGCTGA GCTCAAACCG 
301 CTTGCGCAAT CGCATGCTAC TAAACATAAG ATCCCGATCA AATACCTGGA 
351 ATTCATCTCT GAAGCGATCA TCCATGTTCT GCATTCTAGA CATCCAGGTA 
401 ACTTCGGTGC TGACGCTCAG GGTGCTATGA ACAAAGCTCT CGAGCTGTTC 451 
CGTAAAGATA TCGCTGCTAA GTACAAAGAA CTGGGTTACC AGGGTTAATG 
501 AGGTACC 
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Figure B.3 Plasmid map of pET-30a (+)_Mb.  
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Figure B.4 Nucleotide sequence of plasmid containing vector pET-30a (+) and sperm 
whale myglobin gene (5782bp). 
 
1 ATCCGGATAT AGTTCCTCCT TTCAGCAAAA AACCCCTCAA GACCCGTTTA 
51 GAGGCCCCAA GGGGTTATGC TAGTTATTGC TCAGCGGTGG CAGCAGCCAA 
101 CTCAGCTTCC TTTCGGGCTT TGTTAGCAGC CGGATCTCAG TGGTGGTGGT 
151 GGTGGTGCTC GAGTGCGGCC GCAAGCTTGT CGACGGAGCT CGAATTCGGA 
201 TCCGATATCA GCCATGGCCT TGTCGTCGTC GTCGGTACCT CATTA ACCCT 
251 GGTAACCCAG TTCTTTGTAC TTAGCAGCGA TATCTTTACG GAACAGCTCG  
301 AGAGCTTTGT TCATAGCACC CTGAGCGTCA GCACCGAAGT CACCTGGATG  
351 TCTAGAATGC AGAACATGGA TGATCGCTTC AGAGATGAAT TCCAGGTATT  
401 TGATCGGGAT CTTATGTTTA GTAGCATGCG ATTGCGCAAG CGGTTTGAGC  
451 TCAGCTTCAT GATGCCCTTT TTTCTTAAGG ATAGCACCTA GGGCAGTTAA  
501 CACGGTAACA CCATGTTTTT TCAGATCTTC AGAAGCTTTC ATTTCAGCTT  
551 CAGTTTTCAG ATGTTTGAAA CGATCGAATT TTTCCAGAGT TTCCGGATGA  
601 GATTTGAACA GTCGAATCAA GATGTCCTGA CCATGACCAG CGACGTCAGC 
651 TTCAACTTTA GCCCAAACAT GCAGAACCAG CTGCCATTCA CCTTCAGACA  
701 GAACCATATG TATATCTCCT TCTTAAAGTT AAACAAAATT ATTTCTAGAG 
751 GGGAATTGTT ATCCGCTCAC AATTCCCCTA TAGTGAGTCG TATTAATTTC 
801 GCGGGATCGA GATCGATCTC GATCCTCTAC GCCGGACGCA TCGTGGCCGG 
851 CATCACCGGC GCCACAGGTG CGGTTGCTGG CGCCTATATC GCCGACATCA 
901 CCGATGGGGA AGATCGGGCT CGCCACTTCG GGCTCATGAG CGCTTGTTTC  
951 GGCGTGGGTA TGGTGGCAGG CCCCGTGGCC GGGGGACTGT TGGGCGCCAT 
1001 CTCCTTGCAT GCACCATTCC TTGCGGCGGC GGTGCTCAAC GGCCTCAACC 
1051 TACTACTGGG CTGCTTCCTA ATGCAGGAGT CGCATAAGGG AGAGCGTCGA 
1101 GATCCCGGAC ACCATCGAAT GGCGCAAAAC CTTTCGCGGT ATGGCATGAT  
1151 AGCGCCCGGA AGAGAGTCAA TTCAGGGTGG TGAATGTGAA ACCAGTAACG  
1201 TTATACGATG TCGCAGAGTA TGCCGGTGTC TCTTATCAGA CCGTTTCCCG  
1251CGTGGTGAAC CAGGCCAGCC ACGTTTCTGC GAAAACGCGG GAAAAAGTGG  
1301 AAGCGGCGAT GGCGGAGCTG AATTACATTC CCAACCGCGT GGCACAACAA  
1351 CTGGCGGGCA AACAGTCGTT GCTGATTGGC GTTGCCACCT CCAGTCTGGC  
1401 CCTGCACGCG CCGTCGCAAA TTGTCGCGGC GATTAAATCT CGCGCCGATC  
1451 AACTGGGTGC CAGCGTGGTG GTGTCGATGG TAGAACGAAG CGGCGTCGAA  
1501 GCCTGTAAAG CGGCGGTGCA CAATCTTCTC GCGCAACGCG TCAGTGGGCT  
1551 GATCATTAAC TATCCGCTGG ATGACCAGGA TGCCATTGCT GTGGAAGCTG  
1601 CCTGCACTAA TGTTCCGGCG TTATTTCTTG ATGTCTCTGA CCAGACACCC  
1651 ATCAACAGTA TTATTTTCTC CCATGAAGAC GGTACGCGAC TGGGCGTGGA  
1701 GCATCTGGTC GCATTGGGTC ACCAGCAAAT CGCGCTGTTA GCGGGCCCAT  
1751 TAAGTTCTGT CTCGGCGCGT CTGCGTCTGG CTGGCTGGCA TAAATATCTC  
1801 ACTCGCAATC AAATTCAGCC GATAGCGGAA CGGGAAGGCG ACTGGAGTGC  
169 
1851 CATGTCCGGT TTTCAACAAA CCATGCAAAT GCTGAATGAG GGCATCGTTC  
1901 CCACTGCGAT GCTGGTTGCC AACGATCAGA TGGCGCTGGG CGCAATGCGC  
1951 GCCATTACCG AGTCCGGGCT GCGCGTTGGT GCGGACATCT CGGTAGTGGG 
2001 ATACGACGAT ACCGAAGACA GCTCATGTTA TATCCCGCCG TTAACCACCA  
2051 TCAAACAGGA TTTTCGCCTG CTGGGGCAAA CCAGCGTGGA CCGCTTGCTG  
2101 CAACTCTCTC AGGGCCAGGC GGTGAAGGGC AATCAGCTGT TGCCCGTCTC  
2151 ACTGGTGAAA AGAAAAACCA CCCTGGCGCC CAATACGCAA ACCGCCTCTC  
2201 CCCGCGCGTT GGCCGATTCA TTAATGCAGC TGGCACGACA GGTTTCCCGA  
2251 CTGGAAAGCG GGCAGTGAGC GCAACGCAAT TAATGTAAGT TAGCTCACTC  
2301 ATTAGGCACC GGGATCTCGA CCGATGCCCT TGAGAGCCTT CAACCCAGTC  
2351 AGCTCCTTCC GGTGGGCGCG GGGCATGACT ATCGTCGCCG CACTTATGAC  
2401 TGTCTTCTTT ATCATGCAAC TCGTAGGACA GGTGCCGGCA GCGCTCTGGG  
2451 TCATTTTCGG CGAGGACCGC TTTCGCTGGA GCGCGACGAT GATCGGCCTG  
2501 TCGCTTGCGG TATTCGGAAT CTTGCACGCC CTCGCTCAAG CCTTCGTCAC  
2551 TGGTCCCGCC ACCAAACGTT TCGGCGAGAA GCAGGCCATT ATCGCCGGCA  
2601 TGGCGGCCCC ACGGGTGCGC ATGATCGTGC TCCTGTCGTT GAGGACCCGG  
2651 CTAGGCTGGC GGGGTTGCCT TACTGGTTAG CAGAATGAAT CACCGATACG  
2701 CGAGCGAACG TGAAGCGACT GCTGCTGCAA AACGTCTGCG ACCTGAGCAA  
2751 CAACATGAAT GGTCTTCGGT TTCCGTGTTT CGTAAAGTCT GGAAACGCGG  
2801 AAGTCAGCGC CCTGCACCAT TATGTTCCGG ATCTGCATCG CAGGATGCTG  
2851 CTGGCTACCC TGTGGAACAC CTACATCTGT ATTAACGAAG CGCTGGCATT  
2901 GACCCTGAGT GATTTTTCTC TGGTCCCGCC GCATCCATAC CGCCAGTTGT  
2951 TTACCCTCAC AACGTTCCAG TAACCGGGCA TGTTCATCAT CAGTAACCCG  
3001 TATCGTGAGC ATCCTCTCTC GTTTCATCGG TATCATTACC CCCATGAACA  
3051 GAAATCCCCC TTACACGGAG GCATCAGTGA CCAAACAGGA AAAAACCGCC  
3101 CTTAACATGG CCCGCTTTAT CAGAAGCCAG ACATTAACGC TTCTGGAGAA  
3151 ACTCAACGAG CTGGACGCGG ATGAACAGGC AGACATCTGT GAATCGCTTC  
3201 ACGACCACGC TGATGAGCTT TACCGCAGCT GCCTCGCGCG TTTCGGTGAT  
3251 GACGGTGAAA ACCTCTGACA CATGCAGCTC CCGGAGACGG TCACAGCTTG  
3301 TCTGTAAGCG GATGCCGGGA GCAGACAAGC CCGTCAGGGC GCGTCAGCGG  
3351 GTGTTGGCGG GTGTCGGGGC GCAGCCATGA CCCAGTCACG TAGCGATAGC  
3401 GGAGTGTATA CTGGCTTAAC TATGCGGCAT CAGAGCAGAT TGTACTGAGA  
3451 GTGCACCATA TATGCGGTGT GAAATACCGC ACAGATGCGT AAGGAGAAAA  
3501 TACCGCATCA GGCGCTCTTC CGCTTCCTCG CTCACTGACT CGCTGCGCTC  
3551 GGTCGTTCGG CTGCGGCGAG CGGTATCAGC TCACTCAAAG GCGGTAATAC  
3601 GGTTATCCAC AGAATCAGGGGATAACGCAG GAAAGAACATGTGAGCAAAA  
3651 GGCCAGCAAA AGGCCAGGAA CCGTAAAAAG GCCGCGTTGC TGGCGTTTTT  
3701 CCATAGGCTC CGCCCCCCTG ACGAGCATCA CAAAAATCGA CGCTCAAGTC  
3751 AGAGGTGGCG AAACCCGACA GGACTATAAA GATACCAGGC GTTTCCCCCT  
3801 GGAAGCTCCC TCGTGCGCTC TCCTGTTCCG ACCCTGCCGC TTACCGGATA  
170 
3851 CCTGTCCGCC TTTCTCCCTT CGGGAAGCGT GGCGCTTTCT CATAGCTCAC  
3901 GCTGTAGGTA TCTCAGTTCG GTGTAGGTCG TTCGCTCCAA GCTGGGCTGT  
3951 GTGCACGAAC CCCCCGTTCA GCCCGACCGC TGCGCCTTAT CCGGTAACTA  
4001 TCGTCTTGAG TCCAACCCGG TAAGACACGA CTTATCGCCA CTGGCAGCAG  
4051 CCACTGGTAA CAGGATTAGC AGAGCGAGGT ATGTAGGCGG TGCTACAGAG  
4101 TTCTTGAAGT GGTGGCCTAA CTACGGCTAC ACTAGAAGGA CAGTATTTGG  
4151 TATCTGCGCT CTGCTGAAGC CAGTTACCTT CGGAAAAAGA GTTGGTAGCT  
4201 CTTGATCCGG CAAACAAACC ACCGCTGGTA GCGGTGGTTT TTTTGTTTGC  
4251 AAGCAGCAGA TTACGCGCAG AAAAAAAGGA TCTCAAGAAG ATCCTTTGAT  
4301 CTTTTCTACG GGGTCTGACG CTCAGTGGAA CGAAAACTCA CGTTAAGGGA  
4351 TTTTGGTCAT GAACAATAAA ACTGTCTGCT TACATAAACA GTAATACAAG  
4401 GGGTGTTATG AGCCATATTC AACGGGAAAC GTCTTGCTCT AGGCCGCGAT  
4451 TAAATTCCAA CATGGATGCT GATTTATATG GGTATAAATG GGCTCGCGAT  
4501 AATGTCGGGC AATCAGGTGC GACAATCTAT CGATTGTATG GGAAGCCCGA  
4551 TGCGCCAGAG TTGTTTCTGA AACATGGCAA AGGTAGCGTT GCCAATGATG  
4601 TTACAGATGA GATGGTCAGA CTAAACTGGC TGACGGAATT TATGCCTCTT  
4651 CCGACCATCA AGCATTTTAT CCGTACTCCT GATGATGCAT GGTTACTCAC  
4701 CACTGCGATC CCCGGGAAAA CAGCATTCCA GGTATTAGAA GAATATCCTG  
4751 ATTCAGGTGA AAATATTGTT GATGCGCTGG CAGTGTTCCT GCGCCGGTTG  
4801 CATTCGATTC CTGTTTGTAA TTGTCCTTTT AACAGCGATC GCGTATTTCG  
4851 TCTCGCTCAG GCGCAATCAC GAATGAATAA CGGTTTGGTT GATGCGAGTG  
4901 ATTTTGATGA CGAGCGTAAT GGCTGGCCTG TTGAACAAGT CTGGAAAGAA  
4951 ATGCATAAAC TTTTGCCATT CTCACCGGAT TCAGTCGTCA CTCATGGTGA  
5001 TTTCTCACTT GATAACCTTA TTTTTGACGA GGGGAAATTA ATAGGTTGTA  
5051 TTGATGTTGG ACGAGTCGGA ATCGCAGACC GATACCAGGA TCTTGCCATC  
5101 CTATGGAACT GCCTCGGTGA GTTTTCTCCT TCATTACAGA AACGGCTTTT  
5151 TCAAAAATAT GGTATTGATA ATCCTGATAT GAATAAATTG CAGTTTCATT  
5201 TGATGCTCGA TGAGTTTTTC TAAGAATTAA TTCATGAGCG GATACATATT  
5251 TGAATGTATT TAGAAAAATA AACAAATAGG GGTTCCGCGC ACATTTCCCC  
5301 GAAAAGTGCC ACCTGAAATT GTAAACGTTA ATATTTTGTT AAAATTCGCG  
5351 TTAAATTTTT GTTAAATCAG CTCATTTTTT AACCAATAGG CCGAAATCGG  
5401 CAAAATCCCT TATAAATCAA AAGAATAGAC CGAGATAGGG TTGAGTGTTG  
5451 TTCCAGTTTG GAACAAGAGT CCACTATTAA AGAACGTGGA CTCCAACGTC  
5501 AAAGGGCGAA AAACCGTCTA TCAGGGCGAT GGCCCACTAC GTGAACCATC  
5551 ACCCTAATCA AGTTTTTTGG GGTCGAGGTG CCGTAAAGCA CTAAATCGGA  
5601 ACCCTAAAGG GAGCCCCCGA TTTAGAGCTT GACGGGGAAA GCCGGCGAAC  
5651GTGGCGAGAAAGGAAGGGAAGAAAGCGAAA GGAGCGGGCG CTAGGGCGCT 
5701 GCAAGTGTA GCGGTCACGC TGCGCGTAAC CACCACACCC GCCGCGCTTA  
5751 ATGCGCCGCT ACAGGGCGCG TCCCATTCGC CA 
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APPENDIX C 
 
General information  
Table C1 and C2 list all the primers designed for wild type cytochrome P450cam and 
sperm whale myoglobin and their mutants in this dissertation study. 
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